Wharton

MBA Program in Health Care Management

2019 RESUME BOOK Contents Program Description ...... 4 Curriculum ...... 5 Graduates ...... 6-29 Internship Sponsors...... 30-31 Health Care Program Mentors ...... 32-36 Administration ...... 37 Faculty ...... 38-39

Thank you for your interest in the Wharton MBA Program in Health Care Management. For further information, resumes, and appointments, contact:

June Kinney, Associate Director, MBA Program in Health Care Management The Wharton School University of Pennsylvania 3641 Locust Walk Philadelphia, PA 19104-6218

215.898.6861 | Fax 215.573.2157 email: [email protected]

For information on the Wharton Health Care Management Alumni Association, visit www.whartonhealthcare.org

For detailed information on the Health Care Management Department educational programs, visit http://mba.wharton.upenn.edu/healthcare/ 2019 Health Care Management

MBA Graduates The University of Pennsylvania was founded by Benjamin Franklin in 1740. Although the University carries the name of the Commonwealth, it is not a state university but an independent, private, nonsectarian institution. As one of the country’s earliest educational institutions, it has consistently initiated advances in teaching and research and has steadily generated specialized fields of higher education. Penn, as the University is commonly known, was the first American university to form departments of botany, hygiene and public health, surgical research, and research medicine. The University School of Medicine, formed in 1765, was the first in North America, as was the teaching hospital founded in 1874. The world’s first psychological clinic was opened at Penn in 1896.

The Wharton School, in the same spirit of innovation and excellence, was the world’s first collegiate school of business and management. Founded in 1881 with a gift from Joseph Wharton, the Philadelphia industrialist and philanthropist, the Wharton School undertook the pioneer steps in elevating training for business significantly above its previous level as noncollegiate commercial education. In 1921, the formation of the Graduate Program signaled the advancement of business administration at Wharton to the highest levels of professional education.

Today, the Wharton School has more than 270 faculty members teaching in both the graduate and undergraduate divisions and conducting a continually expanding volume of research. The 1,700 students in the master’s degree program may choose from among more than 200 courses and over 18 majors and concentrations, a variety reflecting the fact that the Wharton education complements the career goals of the individual.

This brochure is provided to introduce you to the 2019 Wharton Health Care Management Program graduates.

We encourage you to consider these individuals for employment.

3 Program Description

The Graduate Program in Health Care Management The Leonard Davis Institute of Health Economics is a full-time 2-year MBA curriculum offered (LDI) is an interdisciplinary center for research by the Health Care Management Department of and education in the organization, financing, the Wharton School. The program, the principal and delivery of health care. Through LDI, University educational effort at the Leonard Davis Institute of Pennsylvania faculty and staff work together of Health Economics, is designed to provide on issues concerning health policy, health managerial and technical expertise to students insurance, managed care, hospitals, corporations, interested in the health care management field. pharmaceutical companies, and other health- By combining the skills of the Wharton disciplines related organizations. Established in 1967, the with sensitivity to the needs of health care providers Institute appropriately bears the name of the late and recipients, the Wharton MBA health care Leonard Davis, one of the foremost innovators in graduate can effectively manage the delivery private health insurance in the United States. He of health services and products at all levels. was the founder of Colonial Penn Group, Inc., a company that has pioneered in insurance for older The Program has produced graduates who have Americans. Both Mr. Davis and Mrs. Sophie Davis chosen careers in hospitals and other medical were generous benefactors to the University of institutions, pharmaceutical, biotechnology and Pennsylvania, contributing basic support for the medical device companies, financial services, activities of the Leonard Davis Institute. entrepreneurial ventures, consulting firms, insurance firms, private health industry, and federal, state, and local government. Many of these MBA graduates now hold positions as chief executive officers, directors, and other key decision makers in health care organizations.

4 Curriculum The Wharton Management Core

All students are required to complete the Wharton Management International Programs: Core. The Wharton School’s core curriculum is designed to Global Modular Courses: Short full-credit courses in an increase crossfunctional integration, extend global experience, intensive workshop format in a country relevant to the topic. strengthen leadership training, and introduce new courses on key management issues. The core curriculum provides Global Immersion Program (GIP): groundwork in basic management disciplines: economics, A high-level survey of the economic, cultural, and geo- finance, financial and cost accounting, management science, political drivers behind regions integral to the global managing people and organizational design, marketing, economy. Students then experience it in-country. operations management, the governmental and legal environment of business, statistics, and strategy. The Health Care Major Courses and Electives: These courses promote an understanding of concepts, Fixed Core: institutions, and issues involved in the organization, • Leadership: Foundations of Teamwork and Leadership financing, and delivery of health services and products • Marketing: Marketing Management in the United States. Health care electives are selected • Microeconomics: Microeconomic Foundation consistent with individual career objectives and interests. • Economics: Advanced Topics in Managerial Economics • Statistics: Regression Analysis for Managers Required • Management Communication: Speaking and Writing • Health Services System • Health Care Field Application Project Flexible Core: Operations, Information, and Decisions Electives • Quality and Productivity • Comparative Health Care Systems • Business Analytics • E-Health: Business Models and Impact • Information Technology and Business Transformation • Financial Management of Health Institutions • Innovation • Healthcare Data & Analytics • Operations Strategy • Health Care Entrepreneurship • Health Care Reform and the Future of Marketing the American Health System • Dynamic Marketing Strategy • Health Care Services Delivery: • Strategic Marketing Simulations A Managerial Economic Approach • Managed Care and the Industrial Organization Communications of Health Care • Advanced Persuasive Speaking • Management & Economics of Pharmaceutical, • Communications Challenges for Entrepreneurs Biotechnology, & Medical Device Industries • Management and Strategy in Medical Devices Accounting and Technology • Financial Accounting • Management of Health Care for the Elderly • Accelerated Financial Accounting • Management of Health Care Service Businesses • Financial and Managerial Accounting • Managing Health Care Organizations • Private Sector Development in Global Corporate Finance Health Development • Corporate Finance • Advanced Study Project • Accelerated Corporate Finance • Introduction to Corporate Finance The Health Care Summer Internship The internship is a 3-month management experience Macroeconomics that provides the health care major an opportunity • Macroeconomics to work with a senior executive in an organization • Introduction to Macroeconomics of particular interest to the student.

Management MBA Electives • Managing the Established Enterprise Opportunities are available for the health care major • Managing the Emerging Enterprise to pursue a second concentration in fields such as entre- preneurship, marketing, finance, or operations, or to Legal Studies & Business Ethics pursue specialized knowledge in areas such as health care • Responsibility in Global Management financing or within specialized segments of the health care • Responsibility in Business industry including managed care organizations, hospitals, pharmaceutical and biotechnology companies, medical device companies, specialty services organizations, and long term care organizations. Graduate courses are available throughout the University.

5 Timothy M. Abbot Shivani Amar Harry A. J. Barber, M.D. [email protected] [email protected] [email protected] Dartmouth College, Hanover, NH Yale University, New Haven, CT University College London, UK B.A., Cum Laude, Chemistry, 2012 B.A., Economics, 2012 B.Sc., Medical Science with Psychology, 2012 M.B.B.S., (Medical Degree) 2015

An opportunity to invest in, build An opportunity to lead operations and An opportunity to improve the lives and direct leading healthcare services strategy in a healthcare organization of other people through healthcare. companies. that aims to improve access to care while lowering healthcare costs. Boston Consulting Group, Boston, MA Zenyth Partners, Great Neck, NY Summer Consultant, Summer 2017 Summer Vice President, Summer/Fall 2018 DaVita, Denver, CO Advised global pharmaceutical on Evaluated behavioral health, specialty Redwoods Associate, Summer 2018 clinical trial strategy to accelerate physician and ambulatory care invest- Developed and launched a branding go-to-market timeline. Worked in ment opportunities for middle-market survey to better understand perspec- conjunction with geo-analytics team healthcare services private equity firm. tives across 3 key audiences. Created (BCG Gamma) and digital investment Developed and presented in-depth a brand strategy framework with and incubation team (BCG Digital investment thesis for future platform. accompanying scorecards to help Ventures) to recruit hospitals and Drove deal process for potential plat- organization approach branding in a patients to trial in 1/3 of industry form acquisition, including developing more structured and data-driven way. average timeline. Facilitated post- the financial model, spearheading the Presented recommendations on brand- merger integration of nascent biotech due diligence process and presenting ing to senior management. into large pharmaceutical company. findings to the investment committee. Independently sourced investment Stanford Health Care, Stanford, CA North Central London Hospitals, opportunity through direct outreach Project Manager, 2015-2017 London, UK and 1:1 meeting with founder. Led pilot of a new primary care model Resident Physician, Managed undergraduate intern. in a clinic. Trained staff on new pro- Internal Medicine 2015-2017 cesses and helped manage the cultural Completed 6 rotations across 2 years Ventus Health Investors, Philadelphia, PA change. Collaborated with clinical as part of UK medical foundation MBA Intern, Winter/Spring 2018 team, facilities, IT, and marketing to training program. Rotations included: Worked directly with managing bring model to fruition. Led process General Surgery, Orthopedic Surgery, partner of small, healthcare-focused improvement project in the Women’s Breast Surgery, Internal Medicine, investment firm to develop investment Cancer Center to improve efficiency Family Practice, and Psychiatry. theses and source/evaluate investment and reduce patient wait times. Awarded North London Quality opportunities. Drove due diligence Improvement Prize for implementing process supporting the acquisition Bain and Company, San Francisco, CA Japanese Lean Management in clinical and integration of 2 multi-site autism Senior Associate Consultant, 2014-2015 setting. Published a number of papers services providers. Associate Consultant, 2012-2014 in international peer-reviewed Advised $1B+ clients from several journals in subjects ranging from Oliver Wyman, New York, NY industries on strategic and operational Cardiology to Cyber-security in a Engagement Manager, 2016-2017 issues; led analysis that informed key hospital setting. Associate, 2014-2016 business decisions such as new market Senior Consultant, 2013-2014 entry, strategic partnerships, M&A, Consultant, 2012-2013 and revised pricing. Led teams of consultants on 15+ strategy engagements for healthcare services and private equity clients. Primary focus areas included market/ competitive due diligence, turn- arounds, growth, and business development. Focused exclusively on healthcare services projects, in particu- lar government programs (Medicare and Medicaid).

6 Pranay Bhatia Jossie A. Ariana Chehrazi [email protected] [email protected] Indian Institute of Technology Bombay, Carreras Tartak Massachusetts Institute of Technology, Mumbai, India jossie.carreras.tartak.wg19 Cambridge, MA B.Tech, Computer Science, 2011 @wharton.upenn.edu B.S., Biology, 2012 New York University, New York, NY B.S., Summa Cum Laude, Marketing, 2013 Perelman School of Medicine at the University of Pennsylvania M.D. Candidate, 2019

An opportunity to harness the power An opportunity to leverage my clinical An opportunity to leverage analytics of emerging health technologies to and managerial skills to improve to inform strategies and operational increase access to patient care. access to healthcare in underserved improvements that transform how populations. patients receive health care. Google Inc., Mountain View, CA Product Manager, Summer 2018 Triple S (Blue Cross Blue Shield of Independence Blue Cross, Philadelphia, PA Developed product strategy for Puerto Rico), San Juan, PR Medical Cost Transformation Intern, Google Ads Attribution (GAA). Summer Consultant, Summer 2018 Summer 2018 Identified opportunities with $1B+ Developed standard operating Sourced, valued, and built business revenue impact, influenced leadership procedures, training materials, and case for utilization management and to invest engineering and design analytical tools for a clinical liaisons payment optimization opportunities resources, and secured formal approval program to reduce medical utilization to decrease medical cost, by ensuring for product requirements. Led innova- in patients with chronic conditions. care delivery in most cost-effective set- tive partnerships with data science Evaluated current reverse colocation ting, reducing unwarranted variation, and other teams to achieve >$500M+ model for behavioral health service abuse, and waste. Contributed to team revenue impact. provision as part of a $40M MBHO savings goal of $220M by identifying contract. Implemented an after visit $1M audit opportunity of outlier pro- Swasth Foundation, Mumbai, India summary at Triple S clinics to improve viders and $4.5M readmissions-related Head of Product, 2014-2017 continuity of care and compliance with overpayment. Partnered with Analytics Led a team of developers at Swasth meaningful use requirements. department to operationalize forecast- (social enterprise operating tech- ing tool to predict uptake and cost of enabled healthcare centers), to build Kaplan, Inc., San Juan, PR and new drugs and medical technology. and launch health IT platform. Owned Philadelphia, PA full product lifecyle, secured first Faculty Member, 2013-2016 Optum Analytics, Boston, MA $100K in revenue from external clients Taught MCAT preparation courses, Senior Client Implementation Manager, and increased end user productivity by tailoring the material when appropri- 2015-2017 30%. Led strategic pivot to focus on ate for each student group. Was Directed $14M+ of technical imple- chronic disease and dental services, consistently eligible for wage raises mentations requiring coordination of successfully raised $3M in grant based on positive student reviews workflow between 5+ internal teams, capital, and transformed operating of my course. Provided individual customization of application features, financial loss to breakeven. counseling on the medical school and validation of data. Managed application process. executive-level client partnerships and McKinsey & Company, Mumbai, India mitigated at-risk client relationships, Business Analyst, 2011-2014 Castleman Disease Collaborative as necessary. Mined client data for Led process transformation of new Network, Philadelphia, PA actionable and cost-saving insights drug launches for an Indian pharma- Research Associate of Inflammatory and presented opportunities to senior ceutical company and secured Pathways, 2015 leadership. $100Mn+ revenue. Formulated Indian Analyzed data from a preliminary healthcare investment strategy for an proteomics study of plasma samples Putnam Associates, Boston, MA international development institution, from idiopathic multicentric Castleman Senior Associate Consultant, 2012-2015 which was adopted by the institution. disease (iMCD) patients, which led to Advised leading global biotech and Achieved supply chain cost reductions a $23K follow-up study. Designed an pharmaceutical clients on growth, worth $45Mn for an Indian pharma- exploratory flow cytometry experi- portfolio management, and pricing/ ceutical multi-national company. ment aimed at characterizing the reimbursement strategies in both myeloid and lymphoid cell populations domestic and international markets. present during active iMCD disease Managed teams of 2–4 analysts, and during remission, which led to a planned and executed 60-person drug $25K flow cytometry follow-up study. launch workshop, and performed research.

7 Chase Culbertson Serena Dasani Jessica P. Dong [email protected] [email protected] [email protected] Davidson College, Davidson, NC Columbia University, New York, NY Dartmouth College, Hanover, NH B.A., History, 2012 B.A., Neuroscience & Behavior, 2013 B.A., Summa Cum Laude, Biology, 2012 Perelman School of Medicine at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA University of Pennsylvania, Philadelphia, PA M.D. Candidate, 2019 M.D. Candidate, 2019

An opportunity to identify and build An opportunity to combine my clinical An opportunity to bridge clinicians and successful healthcare businesses insights with business acumen to health care innovators to transform through a private equity investing role. improve health care delivery globally. delivery systems.

Perimeter Healthcare, Atlanta, GA L.E.K. Consulting, Boston, MA Cityblock Health, New York, NY Summer MBA Associate, Summer 2018 Summer Consultant, Summer 2018 Clinical Operations Fellow, Summer 2018 Enhanced the company’s referral and Evaluated and compiled an analysis Prepared for Cityblock’s first clinic census tracking system and trained 3 of the 2018 United States healthcare go-live by building clinical decision hospital staffs in the system input and system including deep dives on the making aids and operationalizing reporting. Authored company-wide payer, continuum of care, pharmaceu- workflows for community health manual for newly implemented finan- tical, medical device, and healthcare workers. Coordinated clinical opera- cial and operating reporting system. IT landscapes. Presented to C-suite tions, data science, and product Managed pipeline and coordinated private equity investors to help them engineering teams to ensure software diligence on behavioral health targets better understand addressable seg- development for novel care manage- representing $10M in EBITDA. ments within the United States and ment technology met clinical goals Japanese healthcare verticals. and national quality aims. Sheridan Capital Partners, Chicago, IL Associate, Private Equity, 2014-2017 Center for Surgery and Health University of California San Francisco Evaluated leveraged buyouts and Economics, Philadelphia, PA Center for Digital Health Innovation, growth equity investments across the Research Associate, 2014-2017 San Francisco, CA healthcare and consumer products and Conducted patient-centered outcomes Summer Fellow, Summer 2015 services industries for a middle market research on resident involvement in Designed and implemented new private equity fund with $450M of surgical operations in the intensive decision-making tool for hospital IT committed capital. Coordinated care unit, culminating in presentations communications department to curate numerous due diligence streams, and publications. Designed and per- messages to physicians about software managed debt financing processes, formed data analyses utilizing statisti- updates. Reduced extraneous commu- and participated in negotiations cal software to substantiate nication by 74%. Conducted pilot of purchase agreements, debt docu- hypotheses regarding uncommon testing in development of a clinical ments, employment agreements, operations and patient outcomes. team-based digital communication appreciation rights agreements, and platform. other transaction related documents. International Institute of Education, Completed 3 platform investments, Pangkalpinang, Indonesia Close Concerns, San Francisco, CA including 2 specialty practice manage- Fulbright Scholar, 2013-2014 Head, Basic and Clinical Science ment companies and 12 related Taught English, critical reasoning, and (2013-2014), Associate (2012-2013) add-ons. dance to 150 high school students at Chief Technology Officer (2012-2014) the SMAN1 public high school in Synthesized trends in clinical research Piper Jaffray & Co., Charlotte, NC Pangkalpinang. Created educational and commercialization of diabetes and Analyst, Investment Banking, 2012-2014 resources for local community mem- obesity therapeutics by attending Executed sell-side M&A transactions bers regarding the diagnosis and global scientific and health care busi- and provided strategic advisory treatment of women’s health issues. ness conferences, monitoring scientific services for PE-backed middle market Produced and edited a health manual journals, and analyzing manufacturers’ companies. Co-authored confidential for future Fulbright scholars in financial statements; summarized find- information memoranda and Indonesia. ings into digestible reports for various performed valuation analyses using stakeholders: manufacturers, research- LBO and DCF models, comparable ers, clinicians, policymakers, patients. public company analyses, and transac- Managed contractor team to build, tion analyses. test, and roll out new web-based publishing portal.

8 Yi Dong John B. Eppler Roee Farber, M.D. [email protected] [email protected] [email protected] Emory University Goizueta Business School, University of Michigan, Ann Arbor, MI Ben Gurion University, Be’er Sheba, Israel Atlanta, GA B.A., Economics, 2013 B.A., Medical Sciences, 2011 B.B.A., Cum Laude, Finance, 2011 Doctor of Medicine (M.D.), 2015 Technion Israel Institute of Technology M.E., Biomedical Engineering, 2016

An opportunity to help (as an adviser An opportunity to help build and invest An opportunity to invest in and or investor) innovative healthcare in innovative healthcare companies. contribute to development of organizations bring positive changes to innovative digital and biotechnological broader communities and create trans- Lee Equity Partners, New York, NY technologies to solve painful unmet formative impacts on a greater scale. Private Equity MBA Intern, Summer 2018 clinical needs. Evaluated potential investments in Springs Capital, Beijing, China various healthcare services sub-sectors Arix Bioscience, New York, NY Summer Investment Manager, Summer 2018 including autism services, healthcare Summer Associate, Biotech VC, Conducted fundamental equity linen rental services, and medication Summer 2018 research and investment due diligence assisted therapy for opioid addiction. Led diligence efforts on a Series B for the largest hedge fund in China Oversaw all aspects of due diligence; ~$15M investment in a company ($10B AUM in A-Share). Covered TMT managed third party advisors and developing platform therapeutic tech- sector, performed proprietary analysis, junior team members. Received an nology to treat CNS diseases. Created and generated investment recommen- offer to return full-time as a Vice a new database of potential target dations that resulted in portfolio President. companies for investment based on changes. Arix’s strategy. Analyzed and filtered American Capital Equity (now Northlane the database to generate deal flow of Snow Lake Capital, Hong Kong, China Capital Partners), Bethesda, MD 8 companies, in various therapeutic Summer Investment Associate, Private Equity Associate, 2015-2017 areas, including: cancer, ophthalmol- Summer 2018 Member of 10-person team managing ogy, and rare diseases. Initiated coverage on an internet a $1B private equity fund. Performed health company that went IPO in all facets of investment evaluation: Jerusalem Venture Partners (JVP), May 2018. Built financial models and thesis generation, sourcing, due dili- Jerusalem, Israel conducted fundamental research to gence, valuation, and documentation. Associate, 2016-2017 provide investment opinions. Executed 3 transactions resulting in Drove the foundation of JVP’s Digital over $100M of equity deployed in the Health investment vertical ($30M). McKinsey & Company, New York, NY healthcare and technology-enabled Performed local and global market Specialist, 2016-2017 services verticals. Oversaw 3 portfolio analysis. Shaped investment strategy, Senior Business Analyst, 2015-2016 companies, including one of the focusing on software-based technolo- Solutions Analyst, 2012-2015 nation’s largest dental services gies to target clinical unmet needs. Advised state governments on health organizations (Affordable Care), Managed entire deal flow, screened care reform through the development and partnered with management virtually all digital health startups in of value-based payment models. teams to implement key strategic Israel (~300), selected 12, performed Helped payers and providers build initiatives. full technological and financial due strategic insights with implementation diligence. actions to crystalize improvement Jefferies LLC, New York, NY opportunities, refine analytical capa- Investment Banking Analyst, Shaare Zedek Medical Center, bilities, and shape organizational Mergers & Acquisitions, 2013-2015 Jerusalem, Israel decision-making. Developed analytical Executed 7 M&A transactions (buy- Medical Doctor Intern, 2015-2016 toolkits to recognize cost patterns, side, sell-side, and fairness opinions) Practiced medicine in rotations across identify performance drivers, and representing over $2.8B in transaction internal medicine, surgery, pediatrics, evaluate program effectiveness. value. Focused on healthcare and tech- and ICU. Revamped interns’ work pro- nology-enabled services with transac- cesses in neonatal ICU to achieve 30% Verisk Analytics, White Plains, NY tion experience including multi-site decrease in resident workload and Business Analyst, 2011-2012 physical therapy (Athletico), hospice 80% increase in intern rotation satis- Advised financial institutions and care (SouthernCare), and health and faction. Coordinated granting activity payment technology companies on safety analytics software (Appriss). of hospital’s investment arm (Madait), growth strategy, product develop- to support 4 in-house seed medical ment, competitive analyses, and device and digital health companies. benchmarking studies.

9 Kerianne Fernandez Shanel Fields Stas Gorbovitsky kerianne.fernandez.wg19@ [email protected] [email protected] wharton.upenn.edu Cornell University, Ithaca, NY Ben Gurion University, Beer Sheva, Israel Duke University, Durham, NC B.S., Magna Cum Laude, Sociology, 2009 B.Sc., Cum Laude, Biomedical Engineering, B.S., Economics, 2014 2013

A business development role to improve Launch a successful healthcare technol- An opportunity to improve patient’s health outcomes in a collaborative, ogy company that drives a strong lives through integration of medical mission-driven healthcare services clinical, financial, and social impact needs with cutting edge technology organization, incorporating analytics, on society. for a medical device or digital health preventive health, and wellness. company. MD Ally, Philadelphia, PA Clover Health, Jersey City, NJ Founder and CEO, Summer 2018 Amazon Web Services (AWS), Seattle, WA Network Management MBA Intern, Furthered the growth of MD Ally, Senior Technical Product Manager, Summer 2018 a non-emergency 911 navigation solu- Summer 2018 Recommended 5 potential new tion. Executed sales and development Created roadmap and technical markets and delivered Market Entry strategies that bolstered the compa- specifications for new product to be Playbooks informed by synthesizing ny’s sales pipeline and furthered MVP launched and received approval by CMS data, market reports, and inter- development. leadership; identified new product views. Collaborated with Chief opportunity that will reduce custom- Development Officer and Develop- athenahealth, Watertown, MA ers’ implementation times and costs ment, Growth, and Strategic Finance Senior Manager, Enterprise Inside Sales, up to 50% and 30%, respectively, by teams and built financial models for 2015-2017 analyzing customer pain points and vendor negotiations. ISA Manager of the Year 2016. process inefficiencies, and verifying Drove access to healthcare executives technological feasibility. Vinik Family Office, Tampa, FL for the Enterprise Division responsible Venture and Startup Summer Associate, for $450M in revenue and 30% growth 3D Systems Healthcare, Summer 2018 YoY. Team accomplished 119% of Airport City, Israel Conducted due diligence on 6 early- target, or above, each year. Product Manager, 2013-2017 stage, $5M venture capital investments Managed multi-departmental teams for former Fidelity Fund Manager. Manager, Epocrates Marketing, 2014-2015 of 3-5 employees (15 in all) including Promoted internal and external Banner Year Award, 2015 R&D, QA, and HW development; investment in Tampa Bay startups Leveraged quantitative analysis of directed hardware and software simu- by appraising local startup landscape. Epocrates’ 150,000 physician user base lation projects for world’s largest med- to improve campaign results and drive ical device companies in 12+ countries Ernst & Young, New York, NY strategic decision making. Team generating $3M in sales; presented at Heathcare Senior Consultant, 2016-2017 accomplished 114% of target and 20+ global conferences on 3 conti- Financial Services Consultant, 2014-2016 helped increase average deal size nents with average of 15K participants Achieved operational efficiencies and by 423%. gathering 300+ business leads; collabo- regulatory compliance for 6 clients, rated with heads of departments at including 4 in Fortune 50. Co-led Manager, Inside Sales, 2012-2014 5 major hospitals, to shape realistic 2 go-to-market sales campaigns in Managed a collaborative, small group simulation and training curricula. project manager role with combined prospecting team that increased lead outreach to 100 clients and $15M sales production by 506%, while maintain- Israel Defense Forces, Tel Aviv, Israel pipeline. Doubled number served by ing a 34% meeting conversion rate Deputy Head of Department, 2007-2009 a metropolitan county’s Behavioral (versus an industry average of 11%). Deputy Company Commander, 2004-2007 Health Department to 4,000 high-risk By implementing a culture of “teach- Prepared hundreds of intelligence individuals. Facilitated $120M divesti- ers and learners” amongst the team, reports for chief intelligence officer ture for U.S. healthcare payer. Led we were able to bolster collaboration, and prime minister to influence compliance audit of 7 Spanish financial employee engagement, and inventive- strategic decision making; supervised products, resulting in $2B in regulatory ness and end each year 134%, or team of junior officers and research fines and customer repayments. above, annual targets. analysts; trained and mentored team on critical and creative thinking; instructed and educated 65 cadets for military leadership.

10 Matthew J. Gorski Jenny Guyton Dylan Harmon [email protected] [email protected] [email protected] Haverford College, Haverford, PA Yale University, New Haven, CT Cornell University, Ithaca, NY B.A., Political Science, Economics, 2013 B.A., Ethics, Politics and Economics, 2012 B.S., Summa Cum Laude, Applied Economics and Management, 2013

An opportunity to invest in, partner An opportunity to bring innovation to An opportunity to partner with with, and help build market-leading health care delivery systems through and build market-leading healthcare health care companies. investing in and scaling technology and businesses through a private equity services businesses. investing role. Cressey & Company, Chicago, IL Private Equity MBA Intern, Summer 2018 Oxeon Partners, New York, NY Eye Health America, Atlanta, GA Developed and presented investment Town Hall Ventures Intern, Summer 2018 MBA Business Development Intern, theses for 6 health care sectors. Assisted in fundraising and strategic Summer 2018 Spearheaded diligence process for a decisions for new fund. Developed Worked closely with management and potential new platform investment in materials for Limited Partner diligence sponsor owners to complete accretive a provider of autism therapy services, requests. Created financial models to acquisitions of physician practices and ultimately leading to submission of a inform investment allocation decisions. develop organic initiatives to diversify letter of intent to acquire the business. Performed diligence on potential ancillary service capabilities. Construc- Received and accepted offer to return investment and presented memo to ted sophisticated KPI dashboard to full time as a vice president. investment committee. Developed track key metrics. Colla borated with thesis in new market segment and CEO to implement new physician Waud Capital Partners, Chicago, IL sourced potential investments. compensation and communicate Private Equity Associate, 2015-2017 Q2 compensation to physicians. Conducted all aspects of investment Bridgewater Associates, Westport, CT process within the firm’s health care Senior Management Associate, Longitude Capital, Greenwich, CT group. Developed industry white Summer 2018 Associate, 2015-2017 papers and investment theses, led Performed internal consulting projects Evaluated, executed, and monitored financial and business-level diligence, for largest hedge fund in the world investments for $1.2B venture capital presented investment proposals to the with approximately $150B in assets fund with a focus on the biotechnol- firm’s investment committee, and under management. ogy sector. Responsibilities included coordinated third-party diligence investment sourcing, due diligence providers. Completed a total of 19 The Advisory Board Company (ABCO), (technical, commercial, financial), and transactions during 2-year tenure, Washington, DC portfolio company support. Presented including: 3 platform investments Chief of Staff, Technology, 2016-2017 in-depth investment proposals and (dental, physical therapy, and ophthal- Associate Principal, Corporate Strategy participated in all investment commit- mology), 1 exit, and 15 add-on acquisi- and New Product Development, 2014-2016 tee meetings. tions. Managed portfolio companies Led strategic growth initiatives, by attending board meetings, moni- including M&A activities and projects Bank of America Merrill Lynch, toring performance, and developing to develop new capabilities internally. New York, NY and executing strategic, operational Built business case for, and later man- Healthcare Investment Banking Analyst, and financial initiatives. aged, Strategic Partnerships team. 2013-2015 Developed strategic recommendation, Advised on and executed various BMO Capital Markets, New York, NY for chief officers and board, to turn healthcare transactions including Leveraged Finance Investing Banking around technology business. Partnered M&A, leveraged buy-outs, and public Analyst, 2013-2015 with leadership on sensitive project to capital raises. Directed day-to-day Advised, originated, and structured prepare ABCO for sale. execution of transactions, including debt financings to support leveraged managing deal marketing processes, buyouts, M&A financings, dividend Raymond James & Associates, conducting financial analyses and recapitalizations and refinancings Memphis, TN coordinating due diligence. Ranked across all industries. Senior Analyst, 2012-2013 as top-tier analyst. Advised on over 30 potential transac- tions in segments including medical alert devices and internet-of-things.

11 Matthew P. Hinchey Isaac Hodes Hyo Jung [email protected] [email protected] (“Christy”) Hong University of Connecticut, Storrs, CT Carleton College, Northfield, MN B.S., Healthcare Management, 2011 B.A., Mathematics, 2012 [email protected] Harvard College, Cambridge, MA A.B., Magna Cum Laude, Economics 2012 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M.D. Candidate, 2019

An opportunity to work in a strategic An opportunity to improve health care An opportunity to help patients receive role that drives improved healthcare quality and delivery through strategic timely and appropriate care by leverag- outcomes via innovative care models and technological innovation. ing modern capabilities in data analytics and technology applications. and digital communications. Boston Consulting Group, New York, NY Touchdown Ventures, Philadelphia, PA Summer Consultant, Summer 2018 Strategy&, San Francisco, CA MBA Healthcare Investment Intern, Advised healthcare system COO on Summer Senior Associate, Summer 2018 Spring/Summer 2018 developing and implementing a Worked on a large national integrated Involved in launching firm’s first $50M program to manage $100M of margin payor technology strategy and healthcare corporate venture fund improvement over a 5-year timeline. business case development project. with a US hospital system. Performed Coached executives on creating and Analyzed membership retention and system-wide needs assessments with managing plans for over 60 vital growth impact and developed regional executives and front-line personnel to initiatives involving business units cost allocation model post solution identify opportunities that could be including clinical operations, procure- implementation. solved through strategic investments ment, and pharmacy. and sourced deals across 3 key strate- Buoy Health, New York, NY gic areas: neurofeedback devices, AI Hammer Lab, New York, NY Growth Consultant, 2017-Present decision support tools, and nutrition. Product Manager, 2016-2017 Generated online medical articles that Research Fellow, 2015-2016 grew user sessions by 800% (by 17MM Virta Health, San Francisco, CA Software Developer, 2014-2015 sessions) within a year. Authored an Commercialization Strategy Intern, Led a technical team of 5 computer internal strategic report on essential Summer 2017 scientists and senior engineers to landing page components to improve Spearheaded development of commer- deliver computational pipeline for user conversion. Recruited 15 medical cial partnership acquisition strategy. personalized genomic vaccine (phase I content writers and 5 editors; stream- Developed claims savings model via clinical trial), using big data and novel lined the onboarding process and analysis of clinical trial results to artificial intelligence programs to content. quantify the Rx spend reduction across exceed latency requirements so that 10 medication types and over 200 cancer patients could be treated more Laboratory for Quantitative Medicine, patients. quickly. Managed design and engi- Massachusetts General Hospital, neering of genomic data visualization Boston, MA Mercer Health Innovation LABS, San software to aid research of genomic Database Administrator & Analyst, Francisco, CA therapies and big data software 2012-2013 Senior Innovation Imagineer and development, allowing exploration Analyzed medical utilization and Innovation Imagineer, 2015-2017 of tens of millions of genetic variants. spending on lung cancer care at Co-founded Mercer Health Innovation MGH for value-based care redesign. LABS group that evaluated digital Marion Technologies, New York, NY Updated and managed cancer-related health landscape to map each sub-sec- Founder, 2013-2014 billing data in the MGH Cancer tor through meetings with 500+ start- Created first-of-kind fully-automated SuperDatabase. Initiated the Seminar ups. Led partnership development of 3 communications system for use by Series on Quantitative Medicine to solutions projected to generate $10M hospitals to reduce time spent calling facilitate collaboration between in revenue for Mercer and $100M for patients, providing high-touch care individuals in medicine, economics, startup partners. to preempt adverse events and management, engineering, and public improve outcomes. Negotiated with policy. Implemented the HEALTHe- Mercer Health and Benefits, Norwalk, CT CMO of 500-bed hospital to authorize Talker and computerized MGH 2012 Senior Analyst and Analyst, 2012-2015 pilot of product for use with chronic flu shot reminder calls (to 140,000+ Developed financial models for future obstructive pulmonary disease (COPD) patients) and pediatric obesity man- claims risk and implemented new patients, using adaptive messaging to agement program recruiting calls (to client reporting tools to improve improve treatment compliance. 150 homes). deliverable accuracy and replicability.

12 Esther Y. Hsiang Patrick Hunt Jennifer M. Jarboe [email protected] [email protected] [email protected] Harvard University, Cambridge, MA Davidson College, Davidson, NC University of Richmond, Richmond, VA A.B., Cum Laude, Human Evolutionary B.A., Economics, 2012 B.S., Magna Cum Laude and Phi Beta Kappa, Biology, 2012 Biochemistry and Molecular Biology, 2013 Johns Hopkins University School of Medicine, Baltimore, MD M.D. Candidate, 2019

An opportunity to improve patient An opportunity to identify and build An opportunity to reduce disease access, experience, and affordability of market-leading healthcare companies burden and improve global public health health care as a physician-executive in for an established middle-market by forging partnerships between public health systems and services. private equity firm. and private sector organizations.

Hopkins Health Management Advisory Quad-C Management, Inc., Celgene Corporation, Summit, NJ Group, Baltimore, MD Charlottesville, VA MBA Global Marketing Intern, Co-Founder and Project Leader, 2015-2017 MBA Summer Intern, Summer 2018 Summer 2018 Founded graduate health care consult- Evaluated investment opportunities Evaluated viability of 2 life cycle ing group advising Johns Hopkins in the healthcare services and industri- management opportunities for Medicine on strategic and operational als segments for a $1.1B private equity hematology/oncology launch product. issues. Led multiple teams on client fund. Managed financial and business Conducted cross-functional interviews, projects, including designing digital diligence workstreams for physician planned and facilitated 5 workshops, outreach strategy for new accountable practice management investment assessed competitive landscape and care organization and leading quality opportunities in the orthodontics, developed financial model to support assessment of sepsis care in emergency primary care and ophthalmology decision. Directed creative and media department. segments. agencies to build internal launch plan and global omnichannel media strat- The Boston Consulting Group, Bourne Capital Partners, Charlotte, NC egy for unbranded disease awareness New York, NY Private Equity Associate, 2015-2017 campaign. Associate, 2012-2014 Managed private equity transaction Strategy consultant with focus on processes in the pharma and pharma Deloitte Consulting, Arlington, VA biopharmaceuticals and global health services segments from initial diligence Consultant, 2015-2017 delivery. Example projects include through closing, focusing on buyouts, Business Analyst, 2013-2015 developing a commercial digital health privatizations and corporate carve- Evaluated viability of a “beyond the platform for $50B pharmaceutical outs. Supported investment thesis pill” opportunity to differentiate company, designing patient advocacy development and analysis and led a novel immunotherapy product; utilization strategy for drug launch financial and business diligence forecasted 8-year demand and NPV in emerging markets for $11M rare workstreams, including coordination across 5 competitive scenarios; devel- disease pharmaceutical company, and among legal advisors, bankers, and oped regulatory and launch strategies. determining strategy for expansion consultants. Completed 5 total transac- Constructed strategic plan and pro- of a collaborative HIV vaccine research tions: 1 platform investment, 3 tuck-ins cesses to accelerate portfolio of 13 model for global health foundation. and 1 exit. Monitored portfolio com- Zika vaccine candidates to market dur- pany performance of Tanner Pharma ing crisis; segmented and sized global Initiative to End Child Malnutrition, Group, a distributor of drug products. vaccine market; identified opportuni- Massachusetts General Hospital, ties to improve intersectoral collabora- Rukungiri, Uganda Bourne Partners, Charlotte, NC tion. Defined and implemented novel Finance and Clinical Intern, 2012 Investment Banking Analyst, 2014-2015 performance measurement process for Assessed financial sustainability of Managed sell-side and buy-side M&A international public health collabora- malnutrition treatment program at transaction processes from initial dili- tion of 50 countries to prevent, detect, Nyakibale Hospital. Designed and gence through closing across various and respond to emerging health piloted income-generating microenter- healthcare subsegments, including threats. Led team of 9 on a national prise in partnership with hospital consumer healthcare, healthcare committee developing programs to administrators and local microfinance services and pharma services. Managed improve experience and retention of organizations. Improved inpatient day-to-day execution of M&A pro- junior staff. malnutrition protocol. cesses, including creating go-to-market materials, managing deal marketing processes, conducting financial analysis, and managing due diligence.

13 Atasha A. Jordan Emily Kalenik Lisa Kapp [email protected] [email protected] [email protected] Harvard University, Cambridge, MA University of Pennsylvania, Philadelphia, PA University of Pennsylvania, Philadelphia, PA A.B., Neurobiology, 2013 B.A., Magna Cum Laude, Biological Basis B.Sc., Magna Cum Laude, Finance, 2013 Perelman School of Medicine at the University of Behavior, 2013 of Pennsylvania, Philadelphia, PA M.D. Candidate, 2019

An opportunity to innovate strategy An opportunity to work in a strategic An opportunity to drive change in the and operations in mental health care role to support companies bringing healthcare system by investing in and delivery. novel therapies to market and improv- supporting innovative healthcare ing patient access to care through technology and services companies. The Boston Consulting Group, advisory, investment, or business Philadelphia, PA development. KKR, Menlo Park, CA Summer Consultant, Summer 2018 MBA Intern, Summer 2018 Goldman Sachs, New York, NY Developed labor forecasting model Led commercial diligence for $30M Investment Banking Summer Associate, to predict potential labor cost savings EBITDA add-on to portfolio company, Healthcare Group, Summer 2018 for food services company. Modified Covenant Surgical Partners. Identified Advised top pharma, biotech and regressions to predict labor hour needs and evaluated healthcare technology medical device companies on various for various client operating locations. opportunities for new $1.5bn growth transactions, including a spin-off IPO, Created dynamic database for client fund. Spearheaded deep-dive on divestiture and buyside M&A through to prioritize operating locations with medical device sector including evalu- various valuation methods, strategic highest likelihood of achieving cost ating successful medical device exits, asset review and due diligence. savings. initiating relationships with senior Executed a $90M follow-on equity executives, and presenting recommen- offering for a $1.5B biotech company. TriMED Healthcare, LLC, Newtown, PA da tions to healthcare group head. Strategic Consultant, 2013-2018 Accenture, New York, NY Developed strategic marketing plan in Apax Partners, New York, NY Business Strategy Consultant, Life Sciences, collaboration with executive manage- Private Equity Associate, 2015-2017 2014-2017 ment; performed break-even analysis Conducted industry, financial and busi- Business Strategy Analyst, Life Sciences, for go/no-go marketing decision ness diligence to evaluate investments 2013- 2014 resulting in increased monthly website for $50bn AUM global private equity Advised top pharma and biotech views and monthly consumer acquisi- firm. Developed investment theses, companies on market access and digi- tion by 10% and 5%, respectively, via managed third-party advisors, and tal initiatives to improve their value bus and television ads. Engineered and presented analysis to investment proposition to patients, healthcare bolstered company’s “relationship committee. Supported 2 portfolio providers and payers. Select experi- model” by realizing synergies with companies (One Call Care Manage- ence: developed playbook asset to several multi-cultural organizations ment and Genex) by performing design patient engagement programs to recruit employees and consumers. business analysis, planning strategic for pipeline biosimilar products, struc- Reduced company tax expenses by initiatives, and evaluating M&A tured a consortium between a $60B+ $10K through tax reconciliation targets. Executed 2 transactions biotech and various hospitals to collect accounting. Simplified ICD-9/ICD-10 including carve-out of respiratory research data, and developed a global coding procedures to streamline solutions business (renamed Vyaire) patient services model for a $1B+ invoicing processes, reducing task time from Becton Dickinson and acquisition drug as a strong differentiator in the by 75%. Presented medical topics of medical cost containment solutions market. Additionally, contributed to 2 including Alzheimer’s Disease and Fall business, KEPRO. thought capital pieces on how patient Prevention to community members. engagement can bring value to Goldman, Sachs & Co., New York, NY pharma companies. Harvard Project for Asian and Investment Banking Analyst, 2013-2015 International Relations, Cambridge, MA Advised M&A and financing transac- Director of Corporate Relations, 2010-2012 tions across the chemicals, utilities and Reestablished relationships with previ- energy verticals. Executed 5 transac- ous sponsors to bring in $23K surplus tions including IPO of Univar, spin-off for conference in Seoul, South Korea of W.R. Grace, bond financing for (2011); secured $48.5K in new sponsor- W.R. Grace, buyside of Cheminova, ships to improve quality and scale of and sellside of FMC Tronox. conference in Taipei, Taiwan (2012).

14 Colin Keeler Patrick M. Kennedy Daniel D. Kim [email protected] [email protected] [email protected] University of Notre Dame, Notre Dame, IN Dartmouth College, Hanover, NH Georgetown University, Washington, DC B.B.A., Magna Cum Laude, Finance, 2012 B.E., Engineering Sciences, 2011 B.S., Magna Cum Laude, International Politics, A.B., Cum Laude, Engineering Sciences with 2012 High Honors, 2011

An opportunity to build rapidly growing An opportunity to identify and scale An opportunity to drive adoption of healthcare services or technology innovative healthcare companies innovative technology and advanced businesses as an investor or strategy through an equity investment role. analytics to solve global healthcare professional. challenges. Citadel, New York, NY BeenThere Technologies, Philadelphia, PA Surveyor Capital Summer Associate, Johnson & Johnson, San Francisco, CA Co-Founder, 2017-Present Summer 2018 Summer Strategy Manager Co-founded growing marketplace of Initiated long / short equity coverage (Global Health Tech), Summer 2018 over 150 mentors at 20 top MBA pro- on 8 small- and mid-cap healthcare Developed enterprise blueprint for grams advising 100+ applicants in first companies with a focus on medical pursuing artificial intelligence (AI), year of operations. Developed business devices. Developed investment theses machine learning (ML), and chatbot model, supply recruitment techniques, identifying dislocations between technologies. Evaluated 550+ AI/ML operational guidelines and go-to- fundamental equity valuations and providers across sectors and created a market strategy. consensus expectations. multi-level taxonomy of 200+ use cases for enterprise productivity and busi- Salveo Capital / Cornerstone Angels, next47 (Siemens Venture Capital), ness innovation. Crafted an AI/ML Chicago, IL Boston, MA deployment framework including MBA Associate, Summer 2018 Associate, 2015-2017 an overview of emerging capabilities, Vetted startups to support seed / Series Sourced and evaluated new invest- vendor scorecard, and operational A investments of up to $2M in technol- ments for next47’s healthcare and best practices. Presented to executive ogy, software and ancillary cannabis technology teams, including leading leadership. sectors. Created in-depth market due diligence for next47’s investment research in analytical testing space, in STAT-Diagnostica (acquired by Oscar Health, New York, NY leading to conversations with 6 Qiagen). Developed investment theses Medical Operations Associate, 2016-2017 investment opportunities. for nascent markets, including next- Managed 3-member team in driving generation sequencing software and operational buildout and process Sterling Partners, Chicago, IL services, medical imaging analytics improvement across clinical programs Associate, 2015-2017 and process manufacturing software. including utilization management, Evaluated and managed investments Actively supported portfolio compa- care management, and PBM. Built for $5B AUM firm; involved across nies by assisting with financial projec- end-to-end capabilities for a 14-mem- investment lifecycle, including idea tions, collaborating on presentation ber clinical team, led development of generation, valuation, comprehensive materials, and facilitating strategic clinical analytics and queue optimiza- due diligence, collaboration with relationship with Siemens AG. tion dashboards, re-designed trans- management, and sale management. plant management process, and Executed platform, add-on, recapital- Health Advances, Boston, MA managed vendor performance. ization and sale transactions (Platinum Associate, 2015 Dermatology, Affiliated, Livingston Consultant, 2014 Accenture, New York, NY International, Hoffman Southwest, Senior Analyst, 2013 Business Strategy Consultant, 2015-2016 iLaw). Analyst, 2011-2012 Senior Business Analyst, 2014-2015 Strategy consultant to pharmaceutical, Business Analyst, 2012-2014 Lincoln International, Chicago, IL medical device, diagnostic, and finan- Focused on growth strategy and Analyst, 2012-2015 cial service clients. Led project teams strategic cost transformation in the Executed M&A transactions, advised of 2-4 consultants for due diligence, Consumer Goods & Services practice. clients on corporate strategy, and business strategy, market assessment, Supported senior leadership on busi- pitched for new business. Completed health economic and life cycle man- ness development with C-suite clients 10 deals in 3 years, including both agement projects. Chaired firm’s across industries. Project work included buy-side and sell-side engagements. Forecasting and Business Analytics retail clinic strategy, telematics & con- Committee (2013-2015). nected-car strategy, operating model design and zero-based budgeting.

15 Kellee M. Kim Melanie S. Mor Klier Harvard College, Cambridge, MA [email protected] B .A ., Cum Laude, History of Science, 2012 Kirshenbaum, V.M.D. Technion-Israel Institute of Technology, [email protected] Haifa, Israel Cornell University, Ithaca, NY B .Sc ., Industrial Engineering, major in B A. ,. Economics, minors in International Relations Information Systems, 2014 and French, 2008 B .A ., Economics & Management, 2014 Columbia University, New York, NY Certificate in Premedical Sciences, 2012 University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA, V .M .D ., 2017

Build and invest in real estate for bio- An opportunity to develop cross-sectoral An opportunity to develop innovative technology companies, senior citizens, strategies to address healthcare needs. digital health products at a multi- and wellness centers. national healthcare technology McKinsey & Company, New York, NY company. Fifth Wall, Venice, CA Summer Associate, Summer 2018 Summer MBA Associate, Summer 2018 Worked with client leadership on a DocuSign, San Francisco, CA Diligence on 2 retail investments (a corporate strategy to improve perfor- Product Management Intern, Summer 2018 high-end medical scrub company and a mance for a Fortune 50 healthcare Led research and design initiatives wellness, organic spa / facial company) . company . Developed benchmarks, led improving ‘branding’ feature aware- expert interviews, and formulated case ness, discovery, activation, UX, and Objective Capital Partners, San Diego, CA based guidance for C-level decisions . related paid customers conversions; Consultant, Spring 2018 efforts are estimated to increase Worked with bank and healthcare Nightingale Veterinary Partners, retention by 2% and yearly revenue company founders to put together New York, NY by $1 .1M . confidential investor memorandum; Business Analyst, Summer 2017 51% equity sold to private equity at Conducted market analysis and due Cnoga Medical, Caesarea, Israel valuation of $140M . diligence to guide investment deci- Director of Product Management, sions in the small animal veterinary 2015-2017 Assembly Biosciences, San Francisco, CA space; created a market map used Product Manager, 2014-2015 Manager of Corporate and to complete first investment . Led a PM team and 28 engineers to Business Development, 2015-2016 deliver from concept to commercializa- Closed deal with Allergan for $50M Huaxia Dairy LTD, Beijing, China tion the company’s cloud platform of upfront, $630M development mile- Veterinary Consultant, Summer 2015 15 products (Web, Android, iOS) in 18 stones and $2 .15B commercial mile- Coordinated assessments on large- months, resulting in $3M deals within stones . Developed 5-year business scale dairy facilities; developed 6 months . Spearheaded ‘Cnoga Clinic’ plan, working with 4 different teams recommendations for procedural, to enable expansion in Brazil, resulting over 3 weeks to strategize for $100M environ­mental and clinical changes in $1 .2M strategic deals in 2018 . budget . to improve production . Managed cross-functional team of 15 engineers and designers to develop EcoR1 Capital, San Francisco, CA Center on International Cooperation, company’s flagship second generation Analyst, 2013-2015 New York, NY medical device; led mechanical rede- Collaborated with fund founder Research Assistant, 2009-2010 sign, increasing plastic mold yields by to launch EcoR1; as first employee, Conducted research on prioritization 16% and reducing repair time by 50% . supported raising capital, conducted and sequencing in post-crisis states diligence projects, modelled valua- and donor coordination in Haitian Philips Healthcare, Haifa, Israel tions, met independently with over reconstruction . Program Management Engineer, 2012-2014 100 CEOs and pitched over 200 invest- Led product management activities ment ideas . Conducted diligence, lead- Asociación Civil por la Igualdad y la for an internal BI system analyzing ing to investments of up to 5% of Justicia, Buenos Aires, Argentina vendors performance; system reduced fund and contributing to 350% returns Program Development Intern, 2008-2009 order processing time by 25%, over 2 1/2 years and fund growth from Helped develop grant proposals lead-time by 10%, and increased $13M to $300M . Supported fundrais- approved by Tinker Foundation budget forecasting accuracy by 40%, ing of >$180M by writing quarterly and United Nations Development saving $250,000 per year . Oversaw 50+ updates and managing relationship Programme; tracked and advanced outsourced engineering projects and with over 30 limited partners . funding opportunities . 250+ purchase contracts worth $5M+ for 90 international vendors .

16 Tamás R. Kovács Michael R. Kranz Akshat Kumar M.D. [email protected] [email protected] [email protected] Cornell University, Ithaca, NY Hamilton College, Clinton, NY Kasturba Medical College, Manipal, India M.Eng., Engineering Management, 2010 B.A., Mathematics, 2010 Bachelor of Medicine, Bachelor of Surgery B.S., Operations Research and Information (M.B.B.S.), 2010 Engineering, 2009

An opportunity to generate and execute An opportunity to identify and develop An opportunity to apply my problem- commercial and/or business develop- innovative therapeutics through solving skills and strategic thinking to ment strategies that bring cutting-edge investment or business development. transform health care delivery systems medical device technologies to patients and create value for all stakeholders. in need. Goldman Sachs, New York, NY Large Cap Pharma Investment Research McKinsey, New York, NY Nevro, Redwood City, CA Associate, Summer 2018 Summer Specialist, Summer 2018 Strategic Marketing Intern, Summer 2018 Led due diligence for and cowrote Worked for a national commercial Crafted the commercial launch strat- analysis on the US cosmetic botulinum insurer to identify $50M in incremen- egy for a new indication of Nevro’s toxin market. Built comprehensive tal market opportunities. Client work spinal cord stimulation platform. market and valuation models and included conducting 20 broker inter- Established a cross-functional commit- collaborated with senior analysts views, creating models to identify tee to make strategic decisions and across different subsectors and geog- high value prospects, deep diving monitor ongoing progress for the raphies, directly influencing market into account management practices, launch. Generated, prioritized, and share and revenue estimates. and advising on implementation initiated a set of market development of proposed strategies. initiatives associated with the commer- Opus Point Partners, New York, NY cial launch. Analyst, 2013-2017 Rutgers University/Saint Peters Hospital, Junior Analyst, 2011-2013 New Brunswick, NJ Acera Surgical Inc., St. Louis, MO Research Associate, 2010-2011 Attending Physician and Clinical Instructor, Sr. Director, Product Management, Performed due diligence on hundreds 2015-2017 2016-Present of publicly traded healthcare compa- Chief Resident, 2014-2016 Director, Product Management, 2014-2016 nies by analyzing financial, legal, and Resident Physician, Internal Medicine, Manager, Program Development, 2012-2014 medical data, and meeting with 2012-2015 As the company’s first full-time C-suite executives. Built and main- Led interdisciplinary teams to deliver employee, managed many functional tained detailed discounted cash flow inpatient and outpatient medical care areas during tenure, including: and sum-of-the-parts valuation models to more than 5K patients over 5 years. product development, commercial for healthcare companies within Trained medical students and residents manufacturing and supply-chain, investment universe and provided in the specialty of Internal Medicine. quality, regulatory, marketing strat- investment recommendations to Achieved Chief Resident’s award for egy, and clinical support. Spearheaded portfolio managers. ‘leadership and innovation’ in re- the submission and interactive review designing education systems. Created of 3 510(k) applications to the FDA first-of-its-kind night rotation system across Acera’s product portfolio, that ensured 24x7 hospital coverage, resulting in 2 initial clearances and while improving work satisfaction for 1 IFU expansion. residents.

Express Scripts, Beijing, China Welluhealth (Startup that shifts focus Sr. Business Analyst, from disease to wellness for the elderly), International Operations, 2010-2012 Somerset , NJ Collaborated with the president of Business Development Lead, 2016-2017 China Operations to develop and Increased revenues from $1K to $100K present ESI China’s monthly KPI’s in 10 months and generated enroll- to ESI HQ. Served as the HR team’s ment of 300+ Medicare patients by project manager for ESI China’s restructuring operations, devising sourcing initiatives. new marketing strategy and gaining physician buy-in from 3 primary care practices.

17 Yvette Leung Louise Li Sichao (Chelsea) Li [email protected] [email protected] [email protected] Harvard College, Cambridge, MA University of Pennsylvania, Philadelphia, PA Tsinghua University, Beijing, China A.B., Cum Laude, Chemical and B.S.E., Bioengineering, 2012 B.S., Summa Cum Laude, Chemistry, 2012 Physical Biology, 2014 M.S.E., Bioengineering, 2013 University of Pennsylvania, Philadelphia, PA M.S.E., Systems Engineering, 2014

An opportunity to transform patient An opportunity to develop and An opportunity to leverage my health care by developing and commercializing implement innovative strategies at informatics expertise to promote the innovative therapeutics. the intersection of healthcare and digitalization of health care delivery technology. system in developing countries. Celgene, Summit, NJ MBA Marketing Intern, Summer 2018 Deloitte Consulting, New York, NY Johnson & Johnson, Shanghai, China Developed U.S. brand plan for a first- Summer Associate, Summer 2018 IRDP Marketing Intern, Summer 2018 in-class therapy in collaboration with Identified automation opportunities Built up product portfolio and pricing cross-functional partners. Leveraged for a global pharmaceutical company strategy for a leading medical device data analytics to streamline and to drive an enterprise-wide digital BU to achieve $0.5B revenue / 60% improve speaker programming across transformation strategy to improve increase in 2019; interviewed physi- hematology / oncology franchise; pre- business process efficiency. cians, sales managers, and distributors sented key recommendations to senior across 10+ hospitals. franchise leadership. Created digital Genentech, South San Francisco, CA non-personal promotion launch plan Manufacturing Sciences and Technology, Deloitte Consulting, New York, NY for a potential lymphoma therapy. 2015-2017 Summer Associate, Summer 2018 Managed external agency in assessing Operations Rotational Development Developed 3-year deployment plan digital vendor capabilities for Program, 2013-2015 of digital transformation for global lymphoma / myeloid franchise. Led clinical and commercial drug NGO with $550M annual grants; Led manufacturing campaigns as the facilitation of 15 large client work- L.E.K. Consulting, Boston, MA primary engineer while providing shops focused on finance; revamped Senior Associate Consultant, 2017 process and equipment support / 25+ business processes; increased effi- Associate Consultant, 2016-2017 troubleshooting. Completed 4 projects ciency of financial operation by 600%. Associate, 2014-2016 throughout Genentech as part of the Managed teams to conduct primary Operations Rotational Development Children’s Hospital of Philadelphia, and secondary research, model quanti- Program, including Global Quality, Philadelphia, PA tative forecasts, and provide strategic Global Biologics Manufacturing, Data Associate, 2016-2017 recommendations to 25+ biopharma Supply Chain Technical Product Data Analyst, 2014-2016 clients. Examples include orphan prod- Management, and Drug Product Headed analytics team of 3 in develop- uct launch readiness / organizational Operations. ing flagship real-time dashboard to effectiveness, oncology product acqui- promote best practices of patient sition screens, global biosimilar land- GlaxoSmithKline, King of Prussia, PA injury prevention that affect 30K scape assessment, and alternative R&D Co-op, 2012-2013 inpatients/year, decreased injury rates financing mechanisms for antibiotic Collaborated with multiple depart- in high volume/risk units by >50% development. Spearheaded U.S.-wide ments to create a clinical monoclonal within first year; strategized data life sciences initiative to build internal antibody characterization database for infrastructure of capacity management intellectual property for biotech Biopharmaceutical Analytical Sciences program; managed analytics team to organizational scale-up. team. create data visualization tool for real- time resource allocation across hospi- Partners in Health, Lima, Peru tal (520 beds, 12,000+ employees). Tuberculosis Research Intern, 2012 Helped expand patient social services for National Tuberculosis Control Program and Peruvian Ministry of Health, resulting in ~30% increased patient compliance. Recommended improvements to tuberculosis patient nutrition / transportation programs based on 50+ patient interviews.

18 Andrew B. Liss Steffi Liu Derek Lukin [email protected] [email protected] [email protected] Vanderbilt University, Nashville, TN Johns Hopkins University, Baltimore, MD Wesleyan University, Middletown, CT B.A., Economics, 2012 B.S., Biomedical Engineering, Applied B.A., Molecular Biology and Biochemistry, Mathematics and Statistics, 2013 Spanish, 2013

An opportunity to strengthen payer and An opportunity to make a meaningful An opportunity to advise and build provider partnerships while effectively impact on patient care by partnering innovative health care technology deploying and commercializing health with providers to identify and execute and patient engagement companies. system assets. on strategic opportunities. Health Advances, San Francisco, CA Mount Sinai Health System, Kaiser Permanente, Los Angeles, CA Summer Consultant, Summer 2018 New York, NY Strategic Business Initiatives – Collaborated with an orthopedic medi- Product Intern, Summer 2018 Graduate Intern, 2018 cal device company to define product Prepared for the launch of newly Identified need for strategic manage- strategy for an intra-operative data acquired worksite health clinic ment of internal initiatives by gather- collection tool; conducted 10 key opin- by developing employee-focused ing information on 15 diabetes pilots ion leader interviews and presented programs to boost engagement. being run across Southern California. strategic partnership recommenda- Conducted research on NY area health Built business case and model for tions to CEO. Advised a branded plans and employee benefit packages potential partnership to lay founda- pharmaceutical company on loss of to determine optimal service offerings tion for increased automation of dia- exclusivity strategy for an orphan in worksite clinics. Created financial betes care. Developed retail strategy drug; built a sales erosion model and model to forecast ROI for newly for optical stores within Southern developed a list of defensive strategies proposed navigation services product. California. to minimize revenue loss.

Huron Consulting Group, Atlanta, GA Huron Consulting Group, Boston, MA Athenahealth, Boston, MA Revenue Cycle Analyst, 2014-2017 Life Sciences Strategy Associate, 2016-2017 Manager, Product Management, 2017 Advised U.S. health systems on the Developed multi-tumor oncology R&D Senior Associate, Product Innovation, design and implementation of revenue strategy for novel cancer drug by ana- 2015-2016 management software. Expanded lyzing gaps in competitive landscape. Associate, Product Innovation, 2013-2014 reporting capabilities by developing Conducted due diligence for potential Led R&D team focused on driving custom financial data sets, including acquisition of pre-clinical to Phase II patient portal adoption and grew user cash-posting templates and at-risk drugs for Alzheimer’s Disease. base from 5M to 19M users. Built a account ledgers. Partnered with stake- universal patient identity platform to holders to modify billing and collec- Accenture, Boston, MA enable patients to connect health tion team structures, increasing cash Strategy Consultant, 2015-2016 records across multiple health systems recovery rates. Broadened and refined Senior Strategy Analyst, 2014-2015 and third-party applications and existing self-pay policies for 1 client Strategy Analyst, 2013-2014 launched a beta with Apple Health leading to $6M annual increase in net Identified strategies for CEO of Records. Developed a paper state- patient revenue. Fortune 50 pharmaceutical client, ment-based online payment website contributing to achievement of and partnered with MinuteClinic to Cerner Corporation, Kansas City, MO “blockbuster” status with over $1B in launch a beta, leading to $350M in Business Analyst, 2012-2014 drug sales. Led 4-person, India-based annual online payments after full Supported a global healthcare IT team in analyzing electronic medical product rollout. Frequently advised business unit by tracking and fore- records to understand treatment paths enterprise health system executives casting the team’s sales pipeline. across multiple therapeutic areas. on patient engagement strategy and Maintained strong relationships with Created tools to help centralize presented a webinar on the business legacy business partners like IBM and decision-making for 4,000+ person U.S. impact of patient engagement to over HP, while developing proprietary salesforce of a ~$80B pharmaceutical 400 clients. marketing strategies for global clients, company. including regional and national health systems in the U.K. and Canada.

19 Mallika K. Marar Devi Mehrotra Sefan Nazeer [email protected] [email protected] [email protected] University of Pennsylvania, Philadelphia, PA Yale College, New Haven, CT Northwestern University, Evanston, IL B.A., Summa Cum Laude, Economics, 2014 B.S., Economics (with Honors), Molecular, B.A., Economics 2012 Perelman School of Medicine at the University Cellular, and Developmental Biology of Pennsylvania, Philadelphia, PA Albert Einstein College of Medicine, Bronx, NY M.D. Candidate, 2019 M.D. Candidate, 2020

An opportunity to apply my clinical An opportunity to combine my passion An opportunity to work with a dynamic experience and business acumen to for healthcare business with my knowl- mission driven team to provide superior advance the standard of care with edge of clinical medicine to create inno- healthcare service. innovation in health technology, vative solutions for healthcare delivery. therapeutics and care delivery models. HealthCare Partners, Los Angeles, CA Huron Consulting Group, New York, NY MBA Intern, Summer 2018 RTW Investments, New York, NY Summer Associate, Summer 2018 Worked within the Inpatient Research Analyst Intern, Fall 2018 Worked for a multinational pharma- Operations department to identify Performed scientific diligence on ceutical client to assess the commercial a hospital admission reduction applications of emerging treatment opportunity and probability of regula- approach, analyze potential savings / platforms including gene therapies tory approval for a novel pharmaceuti- profitability, and select preferred sites and cancer immunotherapies. cal agent with potential use in to implement the strategy. Also devel- Identified key disease areas with multiple disease areas ($2B market). oped a provider dashboard with key unmet clinical need through curating Resulted in client consideration of performance metrics for regional analyses of disease genetics, patho- asset acquisition and launch in more leadership. physiology and epidemiology, and than 5 international markets. evaluating current standards of care. Wellthie, New York, NY Conducted equity research on biotech- Hicksville Pediatrics, PC Business Analyst, 2016-2017 nology firms developing innovative Board of Directors, 2013-present Performed product management, therapeutics and health policy Consulted for founders by developing development and implementation research to characterize the evolving initial business plan, including vision roles at a Series A-funded healthcare regulatory, payment and organiza- for brand strategy and strategic tech startup. Led product implementa- tional landscape in health care. partnerships. Ongoing work includes tion into 20+ new states as well as negotiations with government and product integration with key data Genentech, South San Francisco, CA commercial payors for value-based partners. Supported business develop- Business Development Summer Associate, reimbursement, and revenue cycle ment efforts through state prioritiza- Summer 2018 optimization with attention to inven- tion and data management. Contributed to due diligence and tory turnover, patient acquisition negotiation efforts to facilitate part- costs, and customer lifetime value. HealthScape Advisors, Chicago, IL nering deals (options, in-licensing) for Senior Consultant, 2014-2016 early stage oncology therapies as part Yale School of Public Health Consultant, 2012-2014 of the Research and Early Develop- Research Associate, 2012-2013 Served as strategy and operations ment organization. Led cancer Conducted healthcare quality research consultant for health plan clients and immunotherapy sourcing efforts for on the role of national quality risk-bearing provider systems. Advised major academic and industry oncology improvement (QI) campaigns on clients through pre- and post-ACA conferences. Created a scientific hospital quality of care and adoption implementation challenges including framework to evaluate novel cell of novel delivery mechanisms. Project risk adjustment impacts and market therapy modalities (e.g. CAR-T, tumor- work included research on a variety strategy. Led workstream for 18 infiltrating lymphocytes), analyzed the of strategies involved in design of QI months on government contract pro- preclinical and clinical development solutions and appropriate outcome posal, focusing on provider network landscape and designed a strategy measures. Resulted in co-authored operations. to assess business development publication in Journal of Hospital opportunities. Medicine.

20 Shaina A. Oake Sonal Panda Andrea Y. Park [email protected] [email protected] [email protected] University of Pennsylvania, Philadelphia, PA Veermata Jijabai Technological Institute, Massachusetts Institute of Technology, B.S.E., Magna Cum Laude, Materials Science Mumbai, India Cambridge, MA and Engineering, 2010 B.Tech. Engineering, Mechanical Engineering, B.S., Materials Science and Engineering, 2013 M.S.E., Bioengineering, 2011 2012

An opportunity to grow innovative bio- An opportunity to innovate healthcare An opportunity to lead teams in a tech companies through an operational, delivery by investing in and supporting strategic role at a life sciences company business development or investing role. healthcare startups. developing solutions in areas of unmet need. Denali Therapeutics, South San Venture University, San Francisco, CA Francisco, CA Investor, Summer 2018 Bain & Company, San Francisco, CA Corporate Development Intern, Deal sourced and reviewed 85 health- Summer Associate, Summer 2018 Summer 2018 care startups employing artificial Led analytical valuation resulting in Developed China partnering strategy, intelligence technologies, conducted $10-15M in possible savings for a large incorporating impact on clinical trial due diligence, drafted investment hospital provider client by implement- strategy. Presented recommendations evaluations and recommendations, ing several initiatives related to hospi- to CFO and COO. Reviewed and influ- and presented to the investment tal laboratories. Researched and enced contracts and term sheets for committee for approval. Invested synthesized governance best practices in-licensing and out-licensing agree- in 4 companies across AI, robotics, for a new committee-based operating ments, including co-development and consumer and marketplaces, and model. Planned and created client co-commercialization agreement with sourced co-investment capital. meeting materials. a profit-split and antibody discovery collaboration with a royalty structure. Asian Heart Institute, Mumbai, India New Leaf Venture Partners, New York, NY Created financial models and deal Director, 2015-2017 Venture Capital Analyst, 2015-2017 approval presentations for Denali Joined as board director to improve Served as sole junior member for a leadership to support business existing operations, build partnerships $1B+ AUM healthcare investment development transactions. Analyzed and diversify business into new seg- fund focused on biopharma, medical landscape and supported scientific ments. Developed a JV for a cancer devices, diagnostics and healthcare diligence evaluation of in-license hospital and created a chain of dental information technology. Monitored opportunities across modalities. clinics. Created 6-person marketing current investments and constructed and sales team, revamped digital financial returns models for new UCLA Technology Development Group, media presence, and increased brand investments in venture fund and Los Angeles, CA awareness by 32% in key markets. public fund. Constructed materials Principal, 2016-2017 for fundraising efforts when raising Entrepreneurship Associate, 2014-2016 Aditya Birla Group – Corporate Strategy $209M third venture fund. Led financial analysis and advised & Business Development, Mumbai, India campus leadership on $1.14B sale of Assistant Manager, 2015 Bank of America Merrill Lynch, Xtandi royalties. Managed sale of Senior Executive, 2013-2015 New York, NY Kybella royalties; worked with invest- Trainee, 2012-2013 Analyst, Healthcare Investment Banking, ment bankers, lawyers and co-owning Developed long-term strategic growth 2013-2015 institution, and presented market and options for existing businesses, such as Executed M&A and capital markets financial opportunity assessments to acrylic fiber, wherein sales increased transactions for life sciences, medical the board. Launched $1.7M UCLA by 27%. Crafted pitches and assisted in technology and healthcare services Innovation Fund to advance valuation and financial modeling for a clients. Formulated standalone, unlicensed technologies. $3.5B cement deal and $500M carbon accretion/dilution, discounted cash fiber deal. Identified and evaluated flow, leveraged buyout and initial ClearView Healthcare Partners, new business opportunities in big data public offering models using projec- Newton, MA and carbon fiber. tions, synergies, debt schedules and Senior Analyst, 2013-2014 pro-forma information. Analyst, 2012-2013 Strategic consulting for pharmaceutical and biotech firms on due diligences, market opportunity assessments and life cycle management opportunities.

21 Cyrus Peyrovian Shannon Ridge Steven Rosen [email protected] [email protected] [email protected] University of Maryland, College Park, MD University of Pennsylvania, Philadelphia, PA Princeton University, Princeton, NJ B.S., Finance and Operations Management, B.S.E., Bioengineering, 2011 A.B., Woodrow Wilson School of Public 2010 and International Affairs, 2013

An opportunity to build and scale An opportunity to launch and scale An opportunity to build leading health healthcare services and technology products, services, and operating care businesses through investment companies. models that improve the quality or management. and accessibility of patient care. FastAuth, Philadelphia, PA LLR Partners, Philadelphia, PA Founder, Summer 2018 Guardant Health, Redwood City, CA MBA Intern, Health Care Private Equity, Developing software to streamline Business Development Intern, Summer 2018 Spring and Summer 2018 the prior authorization process in Developed business plan and strategic Evaluated new investments for $1.2B health care. Designed and demoed partnerships for Guardant Health’s fund. Developed investment thesis, prototype with initial target market. emerging “data as a product” offering built operating model, and prepared Built pipeline representing over 5,000 and gained buy-in from founding CEO, and presented investment committee physicians. COO and other senior leaders. Output materials on merits and risks for a included market landscape and sizing, buy-and-build health services strategy. NaviMed Capital, Arlington, VA financial projections, resource plan, Conducted due diligence for 3 Private Equity Associate, 2015-2017 pricing strategy, sales strategy, and potential investments. Assisted in acquisitions of family / legal recommendations. founder-owned healthcare services American Securities, New York, NY and technology companies. Lead Optum Analytics (formerly Humedica), Strategy Associate, 2015-2017 associate on 3 completed transactions Boston, MA Led commercial due diligence on 7 (1 platform and 2 add-on acquisitions). Product Manager, 2014-2017 prospective investments, collaborating Delivered product roadmaps for with investment team, for $5.0B pri- Healthagen (a division of Aetna), $35M+ annual revenue analytics tools vate equity fund. Conducted strategy New York, NY that allowed healthcare providers to and operational work for 8 portfolio Business Development Senior Analyst, analyze patient health information companies, working directly with 2012-2015 and identify opportunities for CEOs and senior management teams. Assisted in Aetna’s diversification strat- improved quality of care. Managed Projects for portfolio companies egy through partnerships, acquisitions, strategic direction for team of 30+ included market entry and competitive and minority investments. Completed engineers and facilitated product col- analysis, in addition to the creation of strategic partnership between Aetna laborations with leaders across client long-term strategic plans aligned with and a patient portal company, devel- base of 70+ health systems. Achieve- financial targets. oping financial model and competitive ments include scaling Optum’s Registry analysis. Formed term sheets and product from pilot to significant por- McKinsey & Company, Philadelphia, PA market research models for Joint tion product revenue, launching data Business Analyst, 2013-2015 Venture business unit to launch privacy model, and introducing prod- Completed more than 10 strategy and provider-owned health plans. uct usage statistics into broader prod- operations projects for clients includ- uct team’s decision-making processes. ing hospital systems, pharmaceutical SunTrust Robinson Humphrey, New companies, private equity firms, retail York, NY Deloitte Consulting, Boston, MA companies, and government agencies. Health Care Investment Banking Analyst, Consultant, 2013-2014 Performed data analysis, modeling, 2010-2012 Analyst, 2011-2013 primary and secondary research, and Advised healthcare clients on large- workshop facilitation to develop scale operational and technology strategies to meet client objectives. challenges. Project work included Received offer to return as a Senior leading billing process redesign at Associate. subsidiary of $60B health plan and running program management for CRM implementation across $75B biopharma’s IT, sales, and marketing functions.

22 Michele M. Rudolph Andrew H. Scott Raj R. Sridhara [email protected] [email protected] [email protected] Washington University in St. Louis, Georgetown University, Washington, DC Indian Institute of Technology Bombay, India St. Louis, MO B.A., Cum Laude, Economics 2012 B.Tech. and M.Tech. (Dual Degree), B.S., Magna Cum Laude, Aerospace Engineering, 2011 Biomedical Engineering, 2013 Stanford University, Stanford, CA M.S., Management Science and Engineering, 2014

An opportunity to enable the pursuit of An opportunity to leverage my An opportunity to explore the use of new medicines in a pharma or biotech experience designing and implementing advanced analytics tools to transform organization. national-scale digital health initiatives the healthcare provider space. to help shape the emerging future Moderna Therapeutics, Cambridge, MA of healthcare. World Health Organization, Geneva, Business Development, Summer 2018 Switzerland Integrated internal and external per- Amazon, Seattle, WA Polio Eradication Team Associate, spectives to develop recommendations Program Management Intern, Summer 2018 Summer 2018 for pharma partnership strategies, Developed business strategy in new Supported the planning, coordination enabling a clinical-stage company product area (currently under NDA). and future roadmapping process for to benefit from outside funding and the Global Polio Eradication Initiative. expertise. Facilitated negotiations to Accenture, Melbourne, Australia Created a new tool to drive visibility obtain licenses to technology needed Manager – Management Consulting, into the Initiative’s budgetary needs to advance scientific research. 2015-2017 and funding gaps by geography and Successfully led national-scale digital function, to inform the fundraising Bain & Company, New York, NY and health programs. (1) Developed and process and facilitate understanding Chicago, IL piloted a model for third-party app of availability of funds for contingent Consultant, 2016-2017 integration to Australia’s national needs. Senior Associate Consultant, 2015-2016 health record (2) Led service design Associate Consultant, 2013-2015 and transition planning efforts for The Boston Consulting Group, Los Served as client-facing associate on establishment of the New Zealand Angeles, CA and Berlin, Germany projects spanning multiple functions National Telehealth Service – Consultant, 2016-2017 and industries. Project highlights: consolidating 7 non-profit health Associate, 2014-2016 (1) Worked with >$5B healthcare pro- services with over 200 staff in less than Designed population health improve- vider to define new care delivery mod- 5 months, and (3) Led business case for ment programs, identified areas for els to improve profits and quality, (2) a national electronic health record expansion through geographical mod- Served as part of Bain’s private equity for New Zealand. eling, and supported government col- group on 7 due diligences, covering laboration as part of 10-year strategy multiple industries including pharma- Accenture, Washington, DC refresh for major pediatric hospital ceuticals and healthcare providers, Strategy Consultant, 2012-2015 group on U.S. East Coast. Developed (3) Identified profit improvement Strategy consultant with focus on the roadmap and supported imple- opportunities for medtech client. customer experience strategy for large mentation of “next-gen supply chain” health care providers. Collaborated for global pharma firm; efficiency and Regeneron Pharmaceuticals, to found Accenture’s ‘Patient Access’ coordination improvements using Tarrytown, NY offering focused on leveraging tech- internet of things, analytics, etc. pro- Extern, 2016-2017 nology to improve appointment sched- jected to be $0.6B. Led a team of 8 to Led communications, data gathering, uling and coordination of health visits. oversee the planning, design and busi- analysis, and implementation for orga- (1) Led patient experience transforma- ness case for an “Uber-like” radiologist nizational initiative during 6-month tion program at a leading academic platform for a global medical technol- externship, working for head of health system, and (2) Developed ogy client; annual revenues from plat- Late-Stage Clinical Development and business case and operating model form projected to be $300M - $600M. Medical Affairs. Facilitated cross-func- for consolidation of 20 department tional task force, leading interviews billing offices at a top-ranked and focus groups to ensure initiative children’s hospital. best served all stakeholders.

23 Chloe E. Stier Vasanth S. Erica A. Swanson [email protected] [email protected] Stanford University, Stanford, CA Subramanian Stanford University, Palo Alto, CA B.A., Human Biology, 2011 vasanth.subramanian.wg19@ B.A., Human Biology, 2010 wharton.upenn.edu University of Chicago, Chicago, IL A.B., with Honors, Economics and Political Science, 2013

An opportunity to work with a mission- An opportunity to improve care through An opportunity to design and imple- driven organization to advance innova- enhancing the adoption of, and ensur- ment evidence-based solutions that tive care models and value-based care. ing patient access to, innovative bio- improve patient and caregiver lives. pharmaceuticals. Iora Health, Boston, MA DaVita, Denver, CO Summer Associate, Real Estate Analytics, Intercept Pharmaceuticals, New York, Redwood Summer Associate, Summer 2018 Summer 2018 NY Proposed process-based solutions to Developed predictive model to evalu- US Marketing MBA Intern, Summer 2018 improve clinic performance. ate the enrollment potential of new Assessed potential for a strategic sales Conducted 13 clinics visits, interviewed market entry opportunities and exist- initiative to improve uptake of a sec- >40 frontline staff, designed / imple- ing market expansion opportunities. ond-line pharmaceutical therapy for mented national survey and ran metric Built organizational buy-in for a a rare liver disease. Synthesized inputs correlation analysis. Recommendations hybrid quantitative and qualitative from the marketing, sales, market resulted in immediate implementation approach to expansion decision-mak- access, regulatory, legal, and opera- of company-wide improvements. ing. Toured markets and identified tions teams to perform financial and potential real estate opportunities qualitative analysis of different imple- Genome Medical, San Francisco, CA for 2019. mentation options and make a recom- Business Development Manager, 2017 mendation to the U.S. commercial Managed relationships and contract Alliance of Community Health Plans, leadership team. Developed concept negotiations at target companies, Washington, DC materials (including regulatory and leading to 3 initial partnership agree- Manager, Innovation & Analytics, 2017 legal review) to help physicians and ments for the start-up. Business Analyst, 2014-2016 staff in large primary-care offices iden- Used CMS, NCQA and health plan- tify rare-disease patients for potential MedHelp, San Francisco, CA reported data to benchmark our specialist referral. Lead Account Manager, 2016 member plans’ quality, utilization, Co-led a team to create Medtronic’s price and Medicare market perfor- The Boston Consulting Group, New first digital-companion app for contin- mance. Designed and implemented York, NY uous glucose monitoring. Directed virtual and in-person programming Consultant, 2016-2017 identification of customer require- for health plan leaders in the quality Associate, 2014-2015 ments and platform feature ideation. and pharmacy departments. Led PMO for regulatory changes to complete post-merger integration and Janssen Healthcare Innovation (J&J), The Lewin Group, Falls Church, VA legal entity name changes at a global San Diego, CA Research Consultant, 2014 pharmaceutical company, coordinating Commercial Trial Manager, 2013-2016 Senior Research Analyst, 2011-2014 market-specific filing strategies with Managed team of healthcare profes- Consultant providing research, artwork and labeling changeovers to sionals to implement a trial interven- program planning and technical sup- ensure continuous supply and mini- tion for people with Schizophrenia. port to predominantly federal health mize revenue risk. Recommended and Identified unmet need leading to the clients and their grantees. Primary analyzed financial impact of organiza- development of a novel digital inter- contracts supported the CMS Office of tional changes in the Quality unit of a vention, resulting in reduction of the Medicare Ombudsman, the CMMI vaccines manufacturer to realize post- hospitalization days by 27% and Health Care Innovation Awards, the merger synergies. During a year decision to expand to Mt. Sinai. Veteran-Directed Home and abroad in Brussels, Belgium, developed Community-Based Services program improved hiring, training, and feed- Achaogen, South San Francisco, CA and Aging and Disability Resource back processes to support and sustain Strategic Marketing Analyst, 2011-2012 Centers. culture change and improve country- Created, managed, and moderated region collaboration in a global 5 qualitative market research analyses biopharmaceutical company’s EMEA to inform pipeline and pharmaco- Commercial organization. economic value of lead compound.

24 Adam S. Thomas Angela N. Udemba, Pragun Vohra [email protected] [email protected] Yale University, New Haven, CT Ph.D. University of Maryland, College Park, MD B.A., American Studies, 2012 [email protected] B.S., Computer Engineering, University of York, UK B.S., General Biology, 2011 Master of Chemistry, 2009 Imperial College London, UK Ph.D. Medicinal Chemistry, 2013

An opportunity to operate and build An opportunity to work on effective An opportunity to drive significant innovative healthcare technology and teams in an operational and/or value in healthcare through the services companies. strategic role to drive innovations development of novel hardware in the bio-pharmaceutical industry. and software systems. Relay Investments, Boston, MA Summer Associate, Summer 2018 McKinsey & Company, Chicago, IL Histoserv, Inc., Germantown, MD Conducted due diligence, business Summer Associate, Summer 2018 Operations and Software Integration, analysis, and financial modeling for Advised a healthcare client’s leader- Summer 2018 potential private equity investment in ship team on best practices in execu- Developed software and guided a new a global medical simulation software tive support functions. Worked on a process for automated microscope company. Supported diligence on vendor rationalization initiative with slide labeling, yielding a 75% additional 22 investment opportunities the client operational team to identify reduction in required labor hours. with emphasis on health care services cost saving opportunities. Integrated disjointed job fulfillment markets. Developed firm presentations process into a single system. and internal financial models. Deloitte Consulting, London, UK Modernized company network infra- Consultant, 2014-2017 structure and set up a central data athenahealth, Watertown, MA Advised clients on business and tech- repository with multiple failsafes. Corporate Development Senior Associate, nology transformations within the 2015-2017 pharmaceutical and financial services Applied Predictive Technologies, Incubated de novo data analytics industries. Key projects included Arlington, VA service offering, launching 2 pilot leading 3 workstreams to define and Principal Engineer, 2016-2017 engagements with top-10 biopharma- implement processes for migrating Lead Front-End Software Engineer, ceutical companies and strategic a multinational bank’s corporate 2014-2015 partners. Developed business case and customers to a new banking channel, Front-End Software Engineer, 2012-2014 acquisition-oriented entry strategy for as part of a $260M digital transforma- Led multiple large-impact develop- international expansion into Europe. tion. ment teams, including a team of 7 Executed product partnerships with to develop a novel product to help medical laboratory software and GlaxoSmithKline, Harlow, UK restaurants optimize pricing strategy mobile patient management software Credit Intern Research Chemist, 2008-2009 and a 10-person team to create a fully providers. Developed more cost-effective meth- customizable test-summarizing dash- ods for synthesizing pain-relief drugs board, used by over 175 businesses. Axiom Law, New York, NY and validated targets as novel and Developed and taught front-end Sales Strategy & Operations Associate, patentable. development training sessions for 75+ 2014-2015 employees and led recruiting efforts Sales & Account Management Analyst, from the University of Maryland. 2012-2014 Served as business advisor to company Hurdlr, Inc., Washington, DC leadership responsible for ~50% of Lead Front-End Software Engineer, firm revenue. Managed revenue 2015-2016 forecasting, conducted profitability Led mobile front-end development analysis of global sales function, and for a fast-growing user-base. Drove supported organization re-design integrations with and contributed to drive top-line revenue growth. to codebases for 2 other startups. Accelerated client outreach and sales Developed internal tools to boost activities as part of life sciences prac- employee productivity. Reduced app tice team leading to ~35% growth. battery usage by 75%.

25 Greg N. Wallingford, Eric Walter Florence Wang [email protected] [email protected] M.D. Columbia University, New York, NY Colgate University, Hamilton, NY [email protected] B.A., Economics, 2012 B.A., Magna Cum Laude, Economics, University of Notre Dame, Notre Dame, IN Perelman School of Medicine at the Psychology, 2013 B.S., Magna Cum Laude, Science Computing University of Pennsylvania, Philadelphia, PA & Psychology, 2010 M.D. candidate, 2019 University of Texas Southwestern Medical School, Dallas, TX M.D., 2014

To improve healthcare delivery systems An opportunity to apply effective, An opportunity to make innovative for physicians and patients. innovative healthcare management pharmaceutical products more accessible techniques to the global health setting. and affordable to patients all around McKinsey & Company, Dallas, TX the world. Summer Associate, Summer 2018 Possible, Kathmandu, Nepal Identified $35M savings opportunity at Healthcare Finance Intern, Summer 2018 Deloitte Consulting, Paris, France large hospital system by standardizing As part of 3-member team, developed Strategy & Operations Summer Associate, supply utilization for surgical proce- structure and data-gathering plan for Summer 2018 dures. Led meetings with COO, VPs, costing analysis of Bayalpata Hospital, Prepared an all-day greenhouse and surgeons to present analysis, elicit a 3-site Community Health Worker innovation workshop to help a French feedback, and gain buy-in for pro- program and EMR implementation. biotechnology company assess its read- posed action plan. Aligned surgeons, Gathered programmatic and financial iness for implementing continuous operating room staff, and service line data via stakeholder interviews and manufacturing; interviewed industry leadership around feasible implemen- analysis of medical and financial experts from the U.S. and Europe. tation strategies to ensure account- records. Created presentations and Organized a pharmaceutical industry ability and maximize value capture. wrote reports for internal and external conference focused on innovative and communication regarding project connected patient engagement prac- University of Pennsylvania Health methods, goals, and timeline. tices. Recommended sourcing strate- System, Philadelphia, PA gies to reduce supply chain disruptions Attending Physician, 2017-Present Americorps Health Corps, Brooklyn, NY for a French medical device company. Trained medical students and resident Patient Navigator, 2013-2014 physicians in the specialty of emer- Identified and enrolled patients in Deloitte Consulting, New York, NY gency medicine. Led interdisciplinary need of financial support for medica- Consultant, 2015-2017 teams to develop and implement tions. Applied to pharmaceutical com- Business Analyst, 2013-2015 treatment plans for critically ill and panies for support on patients’ behalf. Developed competitive response injured patients at the University Partnered with the hospital pharmacy strategy for a top-3 biotechnology of Pennsylvania Health System, a to manage processing and distribution company’s blood disorder product highly-specialized referral center. of the medications; contacted patients in response to competitor launch. when their refills arrived. Updated the Created optimization recommenda- Stanford Health Care, Stanford, CA employee operations and training tions for a top-3 global pharmaceutical Resident Physician, 2014-2017 manual. company’s R&D organization to Led interdisciplinary teams to develop achieve $3M annual cost savings, and implement treatment plans for Working Families Party, New Paltz, NY evaluated and prioritized the organi- critically ill and injured patients in Field Manager, 2012 zation’s 40+ ongoing efficiency-driven Stanford Emergency Department, Performed door-to-door canvassing initiatives. Streamlined and updated a level 1 trauma center and highly- for a State Senate campaign and the clinical cost metrics for a top-3 medical specialized referral center. Appointed Fight for 15 minimum wage campaign. device company’s $1.5B+ annual Resident Director of Quality & Organized canvassing teams and R&D budget across all business units. Operations to oversee Emergency trained new employees. Managed Designed organization structure and Department process improvement employee data tracking system. processes to support a Japanese projects. pharmaceutical company’s pharmaco- vigilance group transformation into a global organization headquartered in the U.S.

26 Nancy L. Wang Parker L. Wright Yue Xi [email protected] [email protected] [email protected] Yale University, New Haven, CT Harvard College, Cambridge, MA University of Michigan, Ann Arbor, MI B.S., Cum Laude, Distinction in Majors, Biology A.B., Cum Laude, Economics 2011 B.B.A., With High Distinction, Phi Beta Kappa, and Economics, 2014 Finance and Accounting, 2011

An opportunity to enhance the patient An opportunity to work on and lead An opportunity in private equity to experience by advancing innovations effective teams within the healthcare identify and build market-leading that deliver personalized care, improve industry, with responsibility for both businesses. outcomes, and promote collaboration strategy and operations. across the healthcare ecosystem. Oberland Capital, New York, NY Boston Consulting Group, Boston, MA Summer Investment Professional, Celgene Corporation, Summit, NJ Summer Consultant, Summer 2018 Summer 2018 Business Development and Strategy Intern, Worked alongside team of consultants Assessed investment opportunities at Summer 2018 on 2 buyside private equity due healthcare focused investment firm Independently led a strategic assess- diligence projects. Created feasibility ($800M Fund II). Responsible for sourc- ment of artificial intelligence in analysis of cooking oil company’s cus- ing deal flow and conducting due biopharma and collaborated with a tomer growth strategy and developed diligence in the biotechnology sector. cross-functional team to design an local market deep dives for HVAC AI pilot study. Analyzed competitor company’s growth plan. H.I.G. Capital, Miami, FL pipelines for late-stage partnership Private Equity Associate, LBO Group, opportunities and supported diligence Vizient (formerly MedAssets), Atlanta, GA 2014-2017 of Phase II oncology asset. Senior Strategy and Operations Manager, Evaluated and executed investments 2015-2017 as a member of the LBO group Bain & Company, Boston, MA Corporate Development Associate, ($1.0B Fund V). Monitored portfolio Consultant, 2017 2013-2015 companies through attending board Senior Associate Consultant, 2016-2017 Developed and implemented Analytics meetings and supporting management Associate Consultant, 2014-2016 & Advisory Services Segment’s overall teams. Closed 3 platform acquisitions, Management consultant specializing business strategy while working as 1 in the healthcare industry (United in healthcare and private equity. internal strategy consultant leading States Medical Supply) and 2 in the Project highlights: (1) Developed cross-functional teams to develop and chemicals industry (Valtris Specialty value-based care playbook for a execute strategies for growth and Chemicals and Dominion Colour national health insurance company; operational improvement opportuni- Corporation). Completed successful (2) Analyzed local market dynamics to ties. Project work included helping sale of Infogix. Spent 4 months as inform independent practice associa- develop strategy for expansion into Chief of Staff of United States Medical tion acquisition; (3) Led diligence of U.K. market and operational improve- Supply, working directly with the CEO potential targets including a behav- ment projects during post-merger to develop and execute strategic and ioral health provider, patient financing integration. tactical initiatives. platform, and international hospital system. Lincoln International, Chicago, IL Citigroup, New York, NY Investment Banking Analyst, 2011-2013 Investment Banking Analyst, Boston Children’s Hospital, Boston, MA Prepared valuation analyses, LBO Mergers & Acquisitions, 2012-2014 Innovation and Digital Health Accelerator models, offering memorandums and Advised corporate clients and financial Strategy Associate, 2016 company presentations while working sponsors on M&A transactions across Crafted a business plan for a compre- on 10 sell-side and 3 buy-side M&A multiple industries; successfully hensive precision medicine service, deals (7 closed). Worked with 12- executed 4 transactions. Developed incorporating input from 50+ stake- person healthcare team to perform defense strategy for public companies holders (including rare disease industry analysis and coverage within facing shareholder activism. researchers, clinicians, peer hospitals, Diagnostic & Research Tools, Medical diagnostics labs, and local payers). Devices, Healthcare Services and Received approval from the hospital’s Outsourced Services sectors. Executive Committee, resulting in eventual launch of the service in 2017.

27 Elaine Xie Cindy Xin Lucy Yin [email protected] [email protected] Northwestern University, Evanston, IL Xiong Ph.D. Duke University, Durham, NC B.A., Cum Laude, Economics & Mathematical [email protected] B.S., Cum Laude, Economics, Biology, 2014 Methods in Social Sciences, 2013 Shanghai Jiao Tong University, Shanghai, China School of Engineering and Applied Sciences B.S., Biotechnology, 2007 at the University of Pennsylvania, University of Michigan, Ann Arbor, MI Philadelphia, PA Ph.D., Molecular, Cellular and Developmental Master of Computer & Information Biology, 2013 Technology, 2019

An opportunity to bring innovative An opportunity to combine my technical An opportunity to create and commer- technologies and medicines to patients expertise with business knowledge to cialize digital health products, especially with the highest unmet need and bridge invest in high-potential technologies those leveraging analytics and cognitive the healthcare gap between U.S. and that transform healthcare. computing, to improve healthcare. the rest of the world. Lilly Asia Ventures, Menlo Park, CA IBM Watson Health, Raleigh, NC C-Bridge Capital, New York City, NY MBA Intern, Venture Capital, Product Management Intern, Summer 2018 Investment Associate, Summer 2018 Summer & Fall 2018 Led cross-functional team spanning Developed investment thesis on gene Led due diligence to evaluate technol- development, design, and data science therapy and rare disease opportunities ogy, growth opportunities and market to develop and demo UX improve- in China. Sourced new investment potential of biotech companies at ments and new ML model in diabetes opportunities, performed due dili- various stages. Conducted market management mobile app. Created gence, and presented recommenda- landscape analysis for U.S.-China cross product roadmap with development tions to managing directors. border investment opportunities partner, Medtronic, conducting user and licensing deals in healthcare. and market research. Analyzed com- Gilead Sciences, Foster City, CA petitor business models, partnerships, Corporate Development, Summer 2018 Tybourne Capital Management, and marketing efforts to guide Conducted due diligence of multiple Hong Kong, China go-to-market strategy. companies; created board materials to MBA Intern, Hedge Fund Equity Research, share recommendations on M&A and Summer 2018 Big Health, San Francisco, CA partnership strategy. Led cross-func- Performed fundamental analysis on Product Marketing & Growth Intern, tional discussions to build counter- healthcare investment opportunities Summer 2017 offer term sheet for 2 in-licensing for the global Long/Short Equity Fund. Led marketing at Series B digital opportunities with contract of $1B Conducted research and built financial therapeutics company focused on in milestones. models to evaluate Chinese biopharma mental health. Created B2B marketing companies. Led due diligence on cross- strategy and playbook. Designed and Adverum Biotechnologies, Palo Alto, CA over deal of a U.K. biotech company. executed 3 B2B campaigns, deploying Senior Financial Analyst, 2016-2017 A/B testing and channel analytics. Developed partnership strategy Life Science Angels, Palo Alto, CA Partnered with Sales to develop and portfolio prioritization across 8 Investment Committee, 2017-2018 targeted messaging and sales enable- indications. Initiated first company- Evaluated early-stage investment ment content. wide patient engagement effort. opportunities. Managed investor rela- Led post-merger budgeting to assess tions and raised capital from individual Accenture, San Francisco, CA company runway and develop fund- angel investors. Advised entrepreneurs Consultant, 2016-2017 raising strategy. on business and technology strategies Analyst, 2014-2016 that enabled growth opportunities. Led work streams on post-merger ZS Associates, Los Angeles & San integration, growth strategy, and cost Francisco, CA Agenovir Corporation (acquired by reduction projects spanning 3 health Associate Consultant, 2015-2016 Vir Biotech), San Francisco, CA systems, 3 PBMs, 1 pharma manufac- Associate, 2013-2015 Founding Scientist and Group Leader, turer, and 1 medical device company. Developed revenue forecasting models 2015-2017 Founded Health AI community with and scenario analysis across multiple Led the research team to conduct research featured by Google, Forbes, disease areas (osteoporosis, migraine, foundational scientific research for and Rock Health. Alzheimer’s, multiple sclerosis). Led CRISPR treatment of infectious market research of payers and key diseases related cancer. Invented 5 opinion leaders to inform pharmaceu- U.S. patents for treating infectious tical product launch strategy. diseases. Established strategies to build technology leadership of the company. Contributed to raise $10.6M Series A.

28 Daniel B. Ziment [email protected] Emory University, Atlanta, GA B.B.A, Finance and Management, 2012

An opportunity to develop into a thought leader in the healthcare industry.

Goldman Sachs, New York, NY Equity Research Summer Associate, Summer 2018 Conducted research and analysis on investment opportunities within healthcare sector. Created initiation report on single healthcare stock. Constructed proprietary operating and valuation models to support invest- ment recommendation. Presented research to the division’s senior management team.

Evolent Health, Arlington, VA Director, Partner Development, 2017 Associate Director, Partner Development, 2015-2016 Senior Analyst, Partner Development, 2014-2015 Created a new framework to analyze local healthcare market dynamics to identify new business opportunities. Analyzed how local markets across the country were moving to “value-based” health care using new framework. Analyzed financial statements of health systems and provider-owned health plans to identify opportunities for Partner Development executives to discuss with potential clients. Collaborated with senior clinical and operations executives to structure customized service offerings for new clients.

Deloitte Consulting, Atlanta, GA Consultant, 2014 Business Analyst, 2012-2014 Performed analysis and presented rec- ommendations on healthcare projects across strategy, finance and M&A.

29 2018 Internship Sponsors

The following organizations DENALI THERAPEUTICS INTERCEPT PHARMACEUTICALS provided internships for Health Care South San Francisco, CA New York, NY Management Students in Summer 2018. DOCUSIGN IORA HEALTH San Francisco, CA Boston, MA

EYE HEALTH AMERICA JOHNSON & JOHNSON Atlanta, GA San Francisco, CA AMAZON Shanghai, China Seattle, WA FASTAUTH Philadelphia, PA KAISER PERMANENTE AMAZON WEB SERVICES (AWS) Los Angeles, CA Seattle, WA FIFTH WALL Venice, CA KOHLBERG KRAVIS ROBERTS & CO. (KKR) ARIX BIOSCIENCE Menlo Park, CA New York, NY GENENTECH San Francisco, CA L.E.K. CONSULTING BAIN & COMPANY Boston, MA San Francisco, CA GILEAD SCIENCES Foster City, CA LEARN IT BEENTHERE TECHNOLOGIES Baltimore, MD Philadelphia, PA GOLDMAN SACHS New York, NY LEE EQUITY THE BOSTON CONSULTING GROUP New York, NY Boston, MA GOOGLE INC. New York, NY Mountain View, CA LILLY ASIA VENTURE Philadelphia, PA Menlo Park, CA GUARDANT HEALTH C-BRIDGE CAPITAL Redwood City, CA LLR PARTNERS New York, NY Philadelphia, PA HEALTH ADVANCES CELGENE CORPORATION San Francisco, CA MCKINSEY & COMPANY Summit, NJ Chicago, IL HEALTHCARE PARTNERS New York, NY CITADEL Los Angeles, CA Dallas, TX New York, NY HISTOSERV, INC. MD ALLY CITYBLOCK HEALTH Germantown, MD Philadelphia, PA New York, NY HOPKINS HEALTH MANAGEMENT MODERNA THERAPEUTICS CLOVER HEALTH ADVISORY GROUP Cambridge, MA Jersey City, NJ Baltimore, MD MOUNT SINAI HEALTH SYSTEM CRESSEY & CO. HURON CONSULTING GROUP New York, NY Chicago, IL New York, NY NEVRO DAVITA IBM WATSON HEALTH San Francisco, CA Denver, CO Raleigh, NC OBERLAND CAPITAL DELOITTE CONSULTING INDEPENDENCE BLUE CROSS New York, NY New York, NY Philadelphia, PA Paris, France OXEON PARTNERS New York, NY

30 PERIMETER HEALTHCARE Atlanta, GA

POSSIBLE HEALTH Kathmandu, Nepal

QUAD-C, MANAGEMENT, INC. Charlottesville, VA

RELAY INVESTMENTS Boston, MA

SNOW LAKE CAPITAL Hong Kong, China

SPRING CAPITAL Beijing, China

STRATEGY& San Francisco, CA

TOUCHDOWN VENTURES Philadelphia, PA

TRIPLE S (BLUE CROSS BLUE SHIELD, PUERTO RICO) San Juan, Puerto Rico

TYBOURNE CAPITAL Hong Kong, China

VENTURE UNIVERSITY San Francisco, CA

VENTUS HEALTH INVESTORS Philadelphia, PA

WORLD HEALTH ORGANIZATION Geneva, Switzerland

ZENYTH PARTNERS Great Neck, NY

31 2018 Health Care Program Mentors

Mentors are leaders and senior managers ALI BEHBAHANI, M.D. ELIZABETH J. CAMPBELL in the health care field who have agreed to General Partner Principal New Enterprise Associates LLR Partners provide career and professional development Chevy Chase, MD Philadelphia, PA advice and guidance to Health Care RYAN BERGER EDWARD CHAN Management students. Senior Director of Business Development Principal Zynx Health, Part of Hearst Health Network 1315 Capital Los Angeles, CA Philadelphia, PA

ALEXIS BERNSTEIN WILLIS CHANDLER STACY SHELDEN ABRISHAMI Senior Director, Client Strategy & Operations President Strategy Manager, Health Wellframe Health System Services Accenture, LLP Boston, MA AmerisourceBergen Los Angeles, CA Conshohocken, PA NIKHIL BHOJWANI DAVID ALLEN Managing Partner DUSTIN W.M. CHANG Director, Business Development & Licensing - Recon Strategy Global Equities Respiratory & Gastrointestinal & Informatics Cambridge, MA Citadel, LLC Medtronic New York, NY Minneapolis, MN DARREN BLACK Managing Director EILEEN CHEIGH BRETT R. ANDERSON, M.D. Summit Partners Vice President Assistant Professor of Pediatrics, Boston, MA Pfizer Inc. Division of Pediatric Cardiology New York, NY Columbia University Medical Center DAVID S. BLOCK, M.D. New York, NY President GEORGE CHEN, M.D. Gliknik Inc. Senior VP, Global Medicines Development DEEPSHIKHA CHARAN ASHANA, M.D. Baltimore, MD Head, China Development Unit Pulmonary and Critical Care Fellow AstraZeneca China University of Pennsylvania Health System LISA BLUMSTEIN Shanghai, China Philadelphia, PA Partner and Co-Founder TriNet Healthcare Consultants, Inc. VINITA CHHAY, D.M.D. HEATHER ASPRAS Concord, MA Health & Insurance Director, New Product Strategy, Vaccines SME-Cognitive Business Development GlaxoSmithKline THEO BRANDT-SARIF, M.D. IBM Philadelphia, PA Consultant UK Clinical Research Concepts EGEN ATKINSON Los Angeles, CA AMY CHIU Biotechnology Investor Product Manager Vernock Healthcare Capital Partners JASON BRAUNER IBM Watson Health New York, NY Managing Partner San Francisco, CA Recon Strategy VIKRAM BAKHRU, M.D. Cambridge, MA BRIAN G. CHOI, M.D. Chief Operating Officer Chief Medical Information Officer; ConsejoSano, Inc. JOLENE BRESSLER Professor of Medicine & Radiology North Hollywood, CA Associate The George Washington University McKinsey & Co. NEIL E. BANSAL Washington, DC Philadelphia, PA Vice President of Business Development BRETT CHUNG Pharmscript ROBERT BRESSLER Senior Product Manager Somerset, NJ Business Development and Corporate Roche, Sequencing Solutions Finance JOHN BARKETT San Francisco, CA Teladoc Director of Product Marketing and Chicago/New York EDUARDO CISNEROS Policy Affairs Independent Consultant/Executive Coach Willis Towers Watson LUCAS BUCHANAN Inspirate Advisory Services Washington, DC Chief Financial Officer Schaumburg, IL Silk Road Medical JAMIL M. BEG Sunnyvale, CA RYAN COCHRAN Principal Member/Founder 5AM Ventures Diagram HC Boston, MA New York, NY

32 BRETT COHEN DOUGLAS C. FISHER, M.D. SEAN GLEESON, M.D. Chief Operating Officer Partner President Civitas Solutions InterWest Healthcare Partners Partners For Kids, Boston, MA Menlo Park, CA Nationwide Children’s Hospital Columbus, OH PETER CONDON PETER FISHMAN Senior Director, Business Development Executive Director, LETICIA LAZARIDIS GOLDBERG, D.M.D. Calico Life Sciences Jersey Integrated Network, Director of Affordability South San Francisco, CA AVP Care Transformation Optum CarePoint Health System Rio de Janeiro, Brazil EMILIE COUEIGNOUX Jersey City, NJ Associate Director, Business Development NOAH GOODMAN Seattle Genetics AARON FLINK Director, Business Development Bothell, WA Principal Seres Therapeutics Heritage Group Cambridge, MA ANA CRESPO Nashville, TN Senior Product Marketing Manager GARY L. GOTTLIEB, M.D. Auris Surgical Robotics CHRIS FRANCK Chief Executive Officer San Carlos, CA Principal, Life Sciences Partners In Health & Health Care, M&A Boston, MA KENNETH L. CUSTER, PH.D. Deloitte Consulting LLP Director of Portfolio Strategy Parsippany, NJ VIKAS GOYAL and Decision Sciences Principal Eli Lilly and Company SCOTT FREISHTAT SR One Indianapolis, IN Partner Cambridge, MA Ashlar Capital Management, LLC DAVID DENNIS New York, NY TODD GUREN Senior Director, Director, Product Manager Strategy and Business Development J.P. GALLAGHER Regence BlueCross BlueShield Cardinal Health President and CEO Portland, OR Dublin, OH NorthShore University HealthSystem Evanston, IL LOVISA GUSTAFSSON PITAMBER “PITOU” DEVGON, M.D. Assistant Vice President President, Co-Founder MIKE GALLAGHER The Commonwealth Fund Velano Vascular, Inc. Principal New York, NY Philadelphia, PA H.I.G. Capital Miami, FL PHILIP P. GUTRY BENJAMIN DORANZ, PH.D. Executive Director, Business Development President & CEO MICHELE GALLUCCI Regeneron Pharmaceuticals Integral Molecular Vice President Development & Strategy Tarrytown, NY Philadelphia, PA Medocity, Inc. Parsippany, NJ MILES HAMMOND CATHY K. EDDY Senior Analyst - Healthcare President ONNE GANEL Reef Knot Capital Health Plan Alliance VP Business Development Springfield, NJ Irving, TX Sharp Lifescience, USA San Diego, CA JOHN HARROFF MINA EGAN Vice President Managing Director, Business Development LYNN GARBEE H.I.G. Capital The Advisory Board Company Senior Director, New York, NY Washington, DC Reimbursement and Collaborative Care Cigna ANDREW HEDIN BRANDON EINSTEIN, M.D. Bloomfield, CT Vice President Vice President Bessemer Venture Partners Enhanced Healthcare Partners DAN GEOFFRION Cambridge, MA New York, NY Marketing Manager Medtronic LINDSAY HERMAN RAMI ELGHANDOUR Minneapolis, MN Program Manager, Strategy President & CEO Northwestern Medicine Nevro NAVID GHARAVI Chicago, IL Redwood City, CA Vice President RLH Equity JANE HERZECA MING FANG Los Angeles, CA Vice President Operations Vice President Quartet Redmile Group New York, NY San Francisco, CA

33 Health Care Program Mentors

LAURIE HOLDEN MICHAEL KRAMARZ, M.D. MICHAEL C. MENG Director, Integration Investment Research Analyst, Chairman, President & CFO Stryker Spine (Health Care Products) Stellar Health Allendale, NJ Samlyn Capital, LLC New York, NY New York, NY SAM HOLLIDAY HUMAIRA MERCHANT Chief Operating Officer JENNIFER LEE Director, Launch Excellence Fit4D, Inc. Special Projects for the CEO Alnylam Pharmaceuticals, Inc. New York, NY Mixpanel Somerville, MA San Francisco, CA BRIAN HOLZER, M.D. GRETCHEN MILLS CEO ELISABETH LEIDERMAN, M.D. Manager Strategy and Market Research Lacuna Health, Vice President, Corporate Development 3M Health Information Systems A Kindred Healthcare Company Fortress Biotech Murray, UT Louisville, KY New York, NY SACHIYO MINEGISHI BOB HUANG ADAM LESSLER, M.D. Vice President, Lead for Sickle Cell Investment Director Principal Disease Program Seidler Equity Australia Canepa Healthcare bluebird bio Sydney, NSW, Australia New York, NY Cambridge, MA

EMILY JANVEY, M.D. BRIAN LEWANDOWSKI GRANT MITCHELL, M.D. Director Biopharma Analyst and Partner Analytics Engagement Manager KKR Tamarack Capital Management McKinsey & Co. (QuantumBlack division) Menlo Park, CA Carlsbad, CA Silicon Valley, CA

PRASHANTH JAYARAM, M.D. JEFFREY S. LITWIN, M.D. CARTER MONTAGUE Portfolio Manager Chief Operating Officer, Chief Operating Officer Citadel Global Equities Clinical Services Organization Cyft New York, NY WCG Clinical Cambridge, MA Princeton, NJ NITI KADAKIA REGAN MURPHY Manager, Business Development LLUVY (WEI) LIU General Manager & Innovation Consultant The Governance Institute – NRC Health Kaiser Permanente The Boston Consulting Group Chicago, IL Oakland, CA Shanghai DAVID B. NASH, M.D. MIKE KIJEWSKI SARAH LYON Dean Chief Executive Officer, Co-Founder Director, Medtronic Vascular Strategy Jefferson College of Population Health MedCrypt & Portfolio Management Philadelphia, PA Solana Beach, CA Medtronic Plymouth, MN WESLEY NURSS STEPHEN KIM Analyst Vice President VIDUR MAHAJAN, M.D. Marshall Wace Goldman Sachs & Co. Associate Director New York, NY Los Angeles, CA & NY Mahajan Imaging New Delhi, India JIM O’CONNELL TINA KIND CEO and Co-Founder Managing Partner SAMIR MALIK MNI Inc. DTS Group Founder/General Manager Downingtown, PA Orlando, FL Genoa Telepsychiatry New York, NY MATT OSTRUP ERIC KLEIN Therapeutics Analyst Director KRISTEN (MANDERSCHEID) DEKEN Schonfeld Strategic Advisors Bridge Growth Partners Director, Labs Operations New York, NY New York, NY Aetion Boston, MA SHAUNAK PARIKH LYN SALSGIVER KOBSA Principal Vice President Strategy, JAMES MARTINEAU EW Healthcare Partners Regulatory and Community Senior Product Manager New York, NY Health Improvement Flatiron Health Yale New Haven Health System New York, NY ELIZABETH KIERNAN PATTYN New Haven, CT Vice President, Life Sciences ROBERT (“BOB”) C. MCDONALD, M.D. Truveris President New York, NY Aledo Consulting, Inc. Indianapolis, IN

34 JONATHAN PEARLSTEIN BEN ROOKS RAVI N. SHAH, M.D. Sr. Director of Growth Marketing Managing Director Medical Director Castlight Health ST Advisors, Inc. Columbia Psychiatry Faculty Practice San Francisco, CA San Francisco, CA Organization New York, NY BETSY PEPINE DAVID A. ROSMAN, M.D. Broker Owner Service Chief, Outpatient and JONATHAN SHANNON Pepine Realty Ambulatory Imaging, Manager Gainesville, FL Business Development Deloitte Consulting LLP Massachusetts General Hospital Atlanta, GA LISA PERLMUTTER Boston, MA Senior Manager, ED SHENKAN Human-Centered Research and Design MICHAEL ROVINSKY CEO University of Pittsburgh Medical Center Director, Southeast Region Shenkan Advisors Pittsburgh, PA Veralon San Francisco, CA Atlanta, GA GIULIA PETERLONGO DANIEL SIMON Director of Strategy LAURA BRADY SAADE SVP BioPharma Business Development DaVita Director of Strategic Planning Guardant Health Denver, CO UCLA, David Geffen School of Medicine Redwood City, CA Los Angeles, CA JOHN PICASSO ANNE E. SISSEL Analyst CRAIG SAMITT, M.D. Vice President & Head, Ventures Pzena Investment Management President & CEO Baxter Healthcare New York, NY Blue Cross and Blue Shield of Minnesota. Chicago, IL Eagan, MN DAVID PINKERT MAUREEN SPIVACK Co-Founder and President ALI SATVAT Senior Industry Partner Friday Health Plans, Inc. Member New State Capital Partners Denver, CO Kohlberg Kravis Roberts & Co., L.P. (KKR) Larchmont, NY Menlo Park, CA SALLY POBLETE JAMES STANFORD Founder and CEO JOE SCATTERGOOD Co-Founder, Managing Partner Wellthie Associate Director, Marketing Fitzroy Health, LLC New York, NY Loxo Oncology New York, NY Stamford, CT LISA RAMON ROSS STERN Deputy Director of Global Health STEVE SCHRODEL Vice President Pro Mujer, Inc. Vice President, Operations Summit Partners Mexico City, Mexico Iora Health Boston, MA Boston, MA EMILY T. REID CHARLES “SCOTLAND” STEVENS Director, Business Development MATTHEW SCHULZ General Partner Doximity Vice President OrbiMed Advisors LLC San Mateo, CA The Vistria Group New York, NY Chicago, IL PAUL RESNICK, M.D. SUSAN STIMSON Chief Business Officer DAVID M. SCHUPPAN General Manager, SINUVA MabVax Therapeutics Inc. Partner Intersect ENT San Diego, CA The Vistria Group Menlo Park, CA Chicago, IL SANDRA RETZKY, D.O. ILANA SULTAN Medical Officer REBECCA SCHWIETZ Director, Brand Lead, U.S. Food & Drug Administration Senior Vice President, Clinical Services INLYTA US MARKETING, Silver Spring, MD Healthfirst Pfizer Oncology New York, NY Pfizer Inc. JAMES RHODES New York, NY Senior Director, Strategy and SVEN SEYFFERT Business Development General Manager and STEVE SWEENY Children’s Health System of Texas Area Lead, Structural Heart, APAC Director, Corporate Development Dallas, TX Abbott Medtronic Singapore San Francisco, CA MATT RIEKE, M.D. Senior Director, DEEPA SHAH VIC TANDON Global Business Development and Strategy Sr. Director, Growth Sr. Manager, Innovation Product Strategy; Johnson & Johnson Landmark Health Health Innovation Technology team Piscataway, NJ Hermosa Beach, CA Blue Shield of California San Francisco, CA

35 Health Care Program Mentors

BRET TENENHAUS CHRIS WILKERSON Vice President President Great Point Partners EquipSystems, LLC Greenwich, CT New York, NY

MARLON THOMPSON ANDREW W, WONG Vice President, Image Analysis Senior Vice President, & Clinical Solutions (a Danaher Company) Corporate Business Development Leica Biosystems Capella Biosciences, Inc. Newcastle, UK Palo Alto, CA

MAYA TSUKERNIK CHIA WU, M.D. VP, Customer Innovation Orthopaedic Hand Surgeon Aetion, Inc. New York Presbyterian – New York, NY Columbia University New York, NY JOHN URQUHART Partner MO YANG HealthCare Royalty Partners Vice President Boston, MA GI Partners San Francisco, CA DANIEL VAN DEN BERGH Investor DANIEL YIP Kaiser Permanente Ventures Executive Director, Strategic Sales Oakland, CA Intercept Pharmaceuticals New York, NY REED VAN GORDEN Managing Director CAROLINE YORK Deerpath Capital Management, LP Senior Vice President, Operations New York, NY WellDoc, Inc. Columbia, MD NEIL VANGALA Managing Partner BILLY YOUNG PRH + VG Senior Associate San Francisco, CA Zocdoc New York, NY LISA VARSHNEY EVP, Relationship Lead / RADA YOVOVICH Head of Strategy Director of Membership Strategy Heartbeat Oak Street Health New York, NY Chicago, IL

RYAN VASS, M.D. KEELY ZIPP Senior Advisor, Population Health Analytics Vice President, Marketing xG Health (a Geisinger Company) Cybrexa Therapeutics Philadelphia, PA New Haven, CT

JEFF VOIGT THOMAS ZIPP Principal Head of Strategy & Brand Development Medical Device Consultants of Vygen Ridgewood LLC Exton, PA Ridgewood, NJ

DAVE WALTON CEO and Founder Chronicare Newtown, PA

LAUREN GREEN WEISENFELD Deputy Director, Healthy Aging Program Samuels Foundation New York, NY

36 Administration

GEOFFREY M. GARRETT, PH.D. Dean, The Wharton School

HOWARD KAUFOLD, PH.D. Vice Dean and Director, The Wharton Graduate Division

SCOTT E. HARRINGTON, PH.D. Chair, Health Care Management Department, The Wharton School; Director, MBA Program in Health Care Management

JUNE M. KINNEY, M.A. Associate Director, MBA Program in Health Care Management

CHRISTINE ALESZCZYK Administrative Coordinator, MBA Program in Health Care Management

JANICE SINGLETON Administrative Coordinator, MBA Program in Health Care Management

37 Faculty

The Program Faculty are drawn from EZEKIEL J. EMANUEL, M.D., PH.D. JUNE M. KINNEY, M.A. the Wharton School, the School of Diane v.S. Levy and Robert M. Associate Director, Graduate Program Levy University Professor and in Health Care Management; Medicine, the School of Nursing, and Vice Provost for Global Initiatives; Lecturer, Health Care Management, the School of Arts and Sciences at the Professor, Health Care Management, The Wharton School University of Pennsylvania and leading The Wharton School GARY J. KURTZMAN, M.D. health institutions in Philadelphia. BRADLEY M. FLUEGEL Vice President, Life Sciences, Additional support is provided by the Senior VP & Chief Strategy Safeguard Scientifics; Lecturer, Officer, Walgreens; Health Care Management, Fellows and Associates of the Leonard Lecturer, Health Care Management, The Wharton School Davis Institute of Health Economics. The Wharton School RISA LAVIZZO-MOUREY, M.D., M.B.A THOMAS N. GILMORE, M.ARCH. PIK Professor of Population Health Vice President, and Health Equity The Center for Applied Research Inc.; Perelman School of Medicine, School ABBY E. ALPERT, PH.D. Senior Fellow, Health Care Management, of Nursing and The Wharton School Assistant Professor, The Wharton School University of Pennsylvania Health Care Management, The Wharton School JOHN P. GLASER, PH.D. CLAUDIO LUCARELLI, PH.D. Senior Vice President, Client Associate Professor, EUGENIO ANESSI, PH.D. Administration, Cerner Corporation; Health Care Management, Professor, Public Management, Lecturer, Health Care Management The Wharton School Bocconi University Graduate School The Wharton School of Management, Milan, Italy; JEFFREY P. LIBSON, J.D. Lecturer and Senior Fellow, HENRY A. GLICK, PH.D. Partner, Cooley; Health Care Management, Professor of Medicine, Lecturer, Health Care Management, The Wharton School Perelman School of Medicine at The Wharton School the University of Pennsylvania; HARI MAHADEVAN, PH.D. DAVID A. ASCH, M.D., M.B.A. Professor, Health Care Management, Independent Consultant; Executive Director, The Wharton School Penn Medicine Center for Health Lecturer and Senior Fellow, Care Innovation; MATTHEW R. GRENNAN, PH.D. Health Care Management, Professor of Medicine, Assistant Professor, The Wharton School Perelman School of Medicine Health Care Management, INGRID NEMBHARD, PH.D., M.S. at the University of Pennsylvania; The Wharton School Professor, Health Care Management, Fishman Family President’s The Wharton School ATUL GUPTA, PH.D. Distinguished Associate Professor, Assistant Professor, Health Care Management, THOMAS E. BAKER, J.D. Health Care Management, The Wharton School William Maul Measey Professor of The Wharton School Law and Health Sciences, University STEVEN A. NICHTBERGER, M.D. of Pennsylvania Law School; SCOTT E. HARRINGTON, PH.D. Adjunct Professor and Senior Fellow, Professor of Health Care Management, Chair, Health Care Management Health Care Management, The Wharton School Department, and Director, The Wharton School Health Care Management Program, MITESH S. PATEL, M.D. LAWTON R. BURNS, PH.D., M.B.A. The Wharton School Assistant Professor of Medicine, Perelman James Joo-Jin Kim Professor of Health Alan B. Miller Professor of Health Care School of Medicine at the University Care Management, The Wharton School; Management and Business Economics of Pennsylvania School of Medicine; Faculty Co-Director, and Public Policy, The Wharton School Roy and Diana Vagelos Program Assistant Professor of Health Care In Life Sciences & Management ERIC M. HEIL Management, The Wharton School SVP, Chief Commercial Officer MARK V. PAULY, PH.D. PATRICIA M. DANZON, PH.D. Software Solutions, NaviHealth, Inc.; John M. and Thomas L. Bendheim Celia Z. Moh Professor Emeritus Lecturer, Health Care Management, Professor; Professor, Health Care of Health Care Management, The Wharton School Management, Business Economics and The Wharton School Public Policy, The Wharton School; JOHN C. HERSHEY, PH.D. Professor, Economics, College of Arts GUY DAVID, PH.D. Anheuser-Busch Professor Emeritus and Sciences Gilbert and Shelley Harrison of Management Science; and Associate Professor, Health Care Management, WILLIAM P. PIERSKALLA, PH.D. Health Care Management, The Wharton School Professor Emeritus The Wharton School JOHN KIMBERLY, PH.D. BENJAMIN DORANZ, PH.D., M.B.A. Henry Bower Professor of Entrepreneurial President and CEO, Integral Molecular; Studies; Professor of Management, Senior Fellow, Health Care Health Care Management, and Sociology, Management, The Wharton School The Wharton School

38 DANIEL POLSKY, PH.D. RACHEL M. WERNER, M.D., PH.D Robert D. Eilers Professor of Health Care Associate Professor of Medicine, Management and Economics, Perelman School of Medicine at the The Wharton School; University of Pennsylvania School of Professor of Medicine, Medicine; Associate Professor and Senior Perelman School of Medicine Fellow, Operations and Information at the University of Pennsylvania; Management, Health Care Management, Executive Director, Leonard Davis The Wharton School Institute of Health Economics JOHN J. WHITMAN, M.B.A. DOUGLAS A. PRESENT, M.B.A. Executive Director, The TRECS Institute; Investor and Advisor; Lecturer, Health Care Management, Lecturer, Health Care Management, The Wharton School The Wharton School SANKEY V. WILLIAMS, M.D. ARNOLD J. ROSOFF, J.D. Professor of General Professor Emeritus, Internal Medicine; Professor, Legal Studies and Business Ethics; Health Care Management, Lecturer, Health Care Management, The Wharton School The Wharton School

STEPHEN M. SAMMUT Lecturer and Senior Fellow, Health Care Management, Lecturer, Entrepreneurial Programs, The Wharton School

CYNTHIA SCALZI, M.N., PH.D. Professor Emeritus of Nursing and Health Care Management, The Wharton School

J. SANFORD SCHWARTZ, M.D. Leon Hess Professor in Internal The University of Pennsylvania Medicine, Perelman School of Medicine values diversity and seeks talented at the University of Pennsylvania; students, faculty and staff from diverse Professor, Health Care Management, backgrounds. The University of The Wharton School Pennsylvania does not discriminate on the basis of race, sex, sexual JEFFREY H. SILBER, M.D., PH.D. orientation, gender identity, religion, Director, Center for Outcomes Research, color, national or ethnic origin, age, The Children’s Hospital of Philadelphia; JUNE KINNEY disability, or status as a Vietnam Era Professor of Pediatrics and Associate Director, MBA Program Veteran or disabled veteran in the Anesthesiology & Critical Care, in Health Care Management administration of educational policies, Perelman School of Medicine at The Wharton School programs or activities; admissions the University of Pennsylvania; policies; scholarship and loan awards; Professor, Health Care Management, athletic, or other University adminis- The Wharton School tered programs or employment. JEFFREY A. SOLOMON, M.D., M.B.A. Questions or complaints regarding Founding Partner, Infiniti Medical LLC; this policy should be directed to: Lecturer, Health Care Management, Executive Director, The Wharton School Office of Affirmative Action and Equal Opportunity Programs ASHLEY SWANSON, PH.D. Sansom Place East Assistant Professor, 3600 Chestnut Street, Suite 228 Health Care Management, Philadelphia, PA 19104-6106 The Wharton School 215.898.6993 (Voice) KEVIN G.M. VOLPP, M.D., PH.D. 215.898.7803 (TDD) Director, Center for Health Incentives and Behavioral Economics, ©2004, The Trustees of Leonard Davis Institute; the University of Pennsylvania. Professor of Medicine, All rights reserved. Perelman School of Medicine at the University of Pennsylvania; SCOTT E. HARRINGTON, PH.D. Professor, Health Care Management, Director, The Wharton School MBA Program in Health Care Management, Photography of students: adamgierkephotography.com The Wharton School

39 Wharton The Wharton School University of Pennsylvania

MBA Program in Health Care Management 3641 Locust Walk Philadelphia, PA 19104-6218

215.898.6861 fax 215.573.2157